To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CCNL2andAURKAIP1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
832 representative clones for gene CCNL2andAURKAIP1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_030937.4   .a -10 to 3103 1 to 3114 exact RefSeq, AAA   3114/3114
(100 %)
0 diff
(100 %id)
AK225758 Spleen .a -8 to 2102 1 to 2108 A8G G9A A11G G12S S13A ... tiling clone, AAA   2108/2108
(100 %)
1 diff
(100.0 %id)
DA360436 subthalamic nucleus .a -8 to 534 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DB070058 testis .a -8 to 526 2 to 536   capped   535/535
(100 %)
0 diff
(100 %id)
DB094055 testis .a -8 to 520 2 to 530   capped   529/529
(100 %)
0 diff
(100 %id)
DB238236 trachea .a -8 to 570 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA120806 cerebellum .a 1 to 531 10 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
DA224179 brain .a 1 to 581 10 to 590   capped   589/589
(100 %)
0 diff
(100 %id)
DA314361 hippocampus .a 1 to 561 10 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA489135 brain .a 1 to 529 10 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
DA744011   .a 1 to 564 10 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA755962   .a 1 to 569 10 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DA758907   .a 1 to 534 10 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
DB239746 trachea .a 1 to 586 10 to 595   tiling clone, capped   594/594
(100 %)
0 diff
(100 %id)
DB248540 uterus .a 1 to 484 10 to 493   capped   492/492
(100 %)
0 diff
(100 %id)
DB282229 uterus .a 1 to 530 10 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
DB291767 uterus .a 1 to 572 10 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
DA109987 cerebellum .a 1 to 537 9 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DA494155 brain .a 1 to 563 9 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA790309 brain .a 1 to 551 9 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DB241611 stomach, tumor tissue .a 1 to 534 9 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
DB291208 uterus .a 1 to 567 9 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA246016 brain .a 1 to 564 8 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA323414 hippocampus .a 1 to 559 7 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
BX340921   .a 1 to 976 2 to 970       970/970
(100 %)
11 diff
(98.9 %id)
DA631099 Kidney .a 1 to 578 3 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA010104 adrenal gland .a 1 to 554 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA081516 cerebellum .a 1 to 572 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA574834   .a 1 to 556 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA754669   .a 1 to 561 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA774442 brain .a 1 to 573 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA840914 placenta .a 1 to 555 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA218584 brain .a 2 to 676 2 to 677   capped   676/676
(100 %)
2 diff
(99.8 %id)
BI822267 pooled brain, lung, testis .a 3 to 279 1 to 277       277/277
(100 %)
0 diff
(100 %id)
CN482379 eye .a 8 to 654 1 to 647       647/647
(100 %)
0 diff
(100 %id)
BQ109461 pooled brain, lung, testis .a 12 to 682 1 to 671       671/674
(99 %)
3 diff
(99.6 %id)
CB989673 Human Placenta, placenta .a 14 to 681 28 to 698       671/734
(91 %)
11 diff
(98.6 %id)
DA026810   .a 15 to 576 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA059979 cerebellum .a 15 to 576 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA097607 cerebellum .a 15 to 565 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DA379153 thalamus .a 15 to 581 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA413071 thalamus .a 15 to 577 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA626849 Kidney .a 15 to 577 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA741077   .a 15 to 572 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA799299 brain .a 15 to 543 2 to 530   capped   529/529
(100 %)
0 diff
(100 %id)
DA862571 placenta .a 15 to 578 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DB062089 testis .a 15 to 552 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
DB142707 thymus .a 15 to 581 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DB158398 thymus .a 15 to 593 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DB281721 uterus .a 15 to 383 2 to 370   capped   369/369
(100 %)
0 diff
(100 %id)
DB284999 uterus .a 15 to 556 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
AY037150   .a 16 to 2319 1 to 2309 exact AAA   2309/2309
(100 %)
8 diff
(99.7 %id)
BX396746 Placenta Cot 25-normalized .a 16 to 832 1 to 816       816/816
(100 %)
4 diff
(99.6 %id)
CN402136 embryonic stem cells, cell lines H1, H7, andH9 .a 17 to 419 1 to 403       403/403
(100 %)
0 diff
(100 %id)
DA094313 cerebellum .a 18 to 484 2 to 468   capped   467/467
(100 %)
0 diff
(100 %id)
DA192069 amygdala .a 18 to 598 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
DA409156 thalamus .a 18 to 578 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA675175   .a 18 to 602 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
DA688988   .a 18 to 558 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
DB150898 thymus .a 18 to 565 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DB281471 uterus .a 18 to 578 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA503740 brain .a 19 to 569 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DA514871 brain .a 19 to 579 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DB144394 thymus .a 20 to 558 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
CN481810 eye .a 34 to 658 1 to 625       625/625
(100 %)
0 diff
(100 %id)
BU152687 carcinoma, cell line, Prostate .a 35 to 884 1 to 853       853/906
(94 %)
7 diff
(99.3 %id)
CR978029 T-Lymphocytes .a 38 to 650 1 to 613       613/613
(100 %)
0 diff
(100 %id)
CN352585 embryonic stem cells, DMSO-treated H9 cellline .a 49 to 620 1 to 572       572/572
(100 %)
0 diff
(100 %id)
CK825948 Pancreas, Purified pancreatic islet .a 58 to 631 1 to 574     Submitted on the opposite strand 574/574
(100 %)
0 diff
(100 %id)
DN601587 human embryonic stem cells .a 62 to 718 1 to 657       657/657
(100 %)
0 diff
(100 %id)
DA382120 thalamus .a 97 to 650 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA417883 thalamus .a 109 to 673 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
CN352576 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 323 to 555 1 to 233       233/233
(100 %)
0 diff
(100 %id)
CN402135 embryonic stem cells, DMSO-treated H9 cellline .a 330 to 875 1 to 546       546/546
(100 %)
0 diff
(100 %id)
AK293451 cerebellum .a 512 to 1608 1 to 1097       1097/1097
(100 %)
0 diff
(100 %id)
DC302209 cerebellum .a 512 to 1073 1 to 562       562/562
(100 %)
0 diff
(100 %id)
CN402147 embryonic stem cells, DMSO-treated H9 cellline .a 593 to 1336 1 to 744       744/744
(100 %)
5 diff
(99.4 %id)
BG911990 anaplastic oligodendroglioma with 1p/19qloss, brain .a 598 to 1335 1 to 739       739/739
(100 %)
6 diff
(99.2 %id)
CX868189 embryonic stem .a 678 to 1288 1 to 610       610/610
(100 %)
1 diff
(99.9 %id)
CX760378 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 679 to 1403 1 to 725     Submitted on the opposite strand 725/726
(99 %)
2 diff
(99.8 %id)
BG678483 skin, squamous cell carcinoma .a 690 to 1408 1 to 730       730/857
(85 %)
21 diff
(97.6 %id)
BE252968 eye, retinoblastoma .a 697 to 1332 1 to 636       636/636
(100 %)
0 diff
(100 %id)
CN352577 embryonic stem cells, DMSO-treated H9 cellline .a 741 to 1160 1 to 420       420/420
(100 %)
0 diff
(100 %id)
CR990487 T-Lymphocytes .a 742 to 1402 1 to 661       661/661
(100 %)
0 diff
(100 %id)
BM836041 stomach .a 742 to 1241 1 to 500       500/500
(100 %)
0 diff
(100 %id)
CR995733 T-Lymphocytes .a 754 to 1467 1 to 714       714/714
(100 %)
0 diff
(100 %id)
BY795222 eye .a 763 to 1776 1 to 1014       1014/1014
(100 %)
1 diff
(100.0 %id)
BQ707313 Spleen .a 766 to 1676 1 to 921       921/922
(99 %)
21 diff
(97.8 %id)
CN352582 embryonic stem cells, cell lines H1, H7, andH9 .a 823 to 1552 6 to 735       730/735
(99 %)
6 diff
(99.2 %id)
BM919449 pooled pancreas and spleen .a 823 to 1719 20 to 924       905/1093
(82 %)
43 diff
(96.1 %id)
CB154281 Liver .a 842 to 1429 1 to 588       588/588
(100 %)
0 diff
(100 %id)
CB119346 Liver .a 857 to 972 1 to 116       116/116
(100 %)
0 diff
(100 %id)
BG546923 lung .a 864 to 1563 1 to 706       706/895
(78 %)
11 diff
(98.8 %id)
AW160397 brain, frontal lobe .a 892 to 1159 1 to 268   fully sequenced,   268/268
(100 %)
0 diff
(100 %id)
AW160424 brain, frontal lobe .a 892 to 1159 1 to 268   fully sequenced,   268/268
(100 %)
0 diff
(100 %id)
AW163240 brain, frontal lobe .a 892 to 1159 1 to 268   fully sequenced,   268/268
(100 %)
0 diff
(100 %id)
AF087903   .a 944 to 2319 1 to 1374   AAA   1374/1374
(100 %)
6 diff
(99.6 %id)
CD654641 Embryonic Stem cells .a 949 to 1729 773 to 1     Submitted on the opposite strand 773/814
(94 %)
14 diff
(98.3 %id)
DB086504 testis .a 971 to 1504 2 to 535   capped   534/534
(100 %)
0 diff
(100 %id)
AW162017 brain, frontal lobe .a 997 to 1174 178 to 1   fully sequenced,   178/178
(100 %)
0 diff
(100 %id)
AW162041 brain, frontal lobe .a 997 to 1174 178 to 1   fully sequenced,   178/178
(100 %)
0 diff
(100 %id)
AW157237 brain, frontal lobe .a 997 to 1166 170 to 1   fully sequenced,   170/170
(100 %)
0 diff
(100 %id)
AL537194 brain, fetal brain .a 1027 to 1263 1 to 235   fully sequenced,   235/235
(100 %)
0 diff
(100 %id)
CN352580 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1036 to 1655 1 to 620       620/625
(99 %)
1 diff
(99.9 %id)
BG676324 skin, squamous cell carcinoma .a 1052 to 1796 1 to 749       749/940
(79 %)
23 diff
(97.6 %id)
CD632896   .a 1054 to 1789 1 to 733       733/733
(100 %)
3 diff
(99.6 %id)
AV647184 corresponding non cancerous liver tissue .a 1066 to 1476 1 to 411     Submitted on the opposite strand 411/411
(100 %)
0 diff
(100 %id)
CB216522 normal endometrium, mid-secretory phase,cycle day 23, uterus .a 1073 to 1714 1 to 642       642/642
(100 %)
0 diff
(100 %id)
CR994039 T-Lymphocytes .a 1074 to 1758 1 to 686       686/689
(99 %)
5 diff
(99.3 %id)
CD632897   .a 1098 to 1858 768 to 8       761/768
(99 %)
0 diff
(100 %id)
AL534032 brain, fetal brain .a 1101 to 1999 1 to 895       895/895
(100 %)
8 diff
(99.2 %id)
AA335615 epididymis .a 1102 to 1315 1 to 214       214/214
(100 %)
0 diff
(100 %id)
AL834432 melanoma (MeWo cell line) .a 1120 to 3103 1 to 1984   tiling clone, available from DKFZ, AAA   1984/1984
(100 %)
1 diff
(100.0 %id)
BG696267 skin .a 1121 to 1799 1 to 679       679/679
(100 %)
0 diff
(100 %id)
CU449796 epidermis .a 1146 to 1952 7 to 813       807/813
(99 %)
7 diff
(99.2 %id)
BU528657 epidermoid carcinoma, cell line, lung .a 1170 to 1910 1 to 752       752/955
(78 %)
20 diff
(98.0 %id)
BF341821 brain, glioblastoma with EGFR amplification .a 1172 to 1953 12 to 793       782/996
(78 %)
34 diff
(96.6 %id)
AL537193 brain, fetal brain .a 1202 to 2079 883 to 5   fully sequenced,   879/883
(99 %)
0 diff
(100 %id)
TI_149274554   .a 1223 to 2107 968 to 88   AAA   881/1009
(87 %)
16 diff
(98.5 %id)
BX396745 Placenta Cot 25-normalized .a 1231 to 2100 885 to 16       870/877
(99 %)
0 diff
(100 %id)
TI_154121268   .a 1260 to 2107 928 to 88   AAA   841/1003
(83 %)
16 diff
(98.5 %id)
AA410607 ovarian tumor, ovary .a 1271 to 1727 1 to 457       457/457
(100 %)
4 diff
(99.2 %id)
BE140540 head_neck .a 1280 to 1441 162 to 1     Submitted on the opposite strand 162/162
(100 %)
0 diff
(100 %id)
AW806798 stomach .a 1286 to 1441 1 to 156       156/156
(100 %)
0 diff
(100 %id)
TI_57151671   .a 1314 to 2109 33 to 832       800/925
(86 %)
16 diff
(98.3 %id)
TI_154107294   .a 1317 to 2107 871 to 83   AAA   789/927
(85 %)
4 diff
(99.6 %id)
BI763861 pooled colon, kidney, stomach .a 1318 to 2109 1 to 796       796/889
(89 %)
14 diff
(98.5 %id)
BE140546 head_neck .a 1333 to 1441 109 to 1     Submitted on the opposite strand 109/109
(100 %)
0 diff
(100 %id)
BI837213 pooled pancreas and spleen .a 1335 to 2169 1 to 841       841/841
(100 %)
10 diff
(98.9 %id)
TI_57167892   .a 1335 to 2169 71 to 911       841/911
(92 %)
6 diff
(99.4 %id)
CU453758 epidermis .a 1350 to 2079 736 to 7     Submitted on the opposite strand 730/736
(99 %)
0 diff
(100 %id)
CU445760 epidermis .a 1353 to 2079 733 to 7     Submitted on the opposite strand 727/733
(99 %)
0 diff
(100 %id)
CR988745 T-Lymphocytes .a 1354 to 1672 1 to 319       319/319
(100 %)
0 diff
(100 %id)
TI_149275876   .a 1355 to 2107 839 to 88   AAA   752/992
(75 %)
9 diff
(99.1 %id)
CA447056 Chondrosarcoma, Left Pubic Bone .a 1374 to 2107 752 to 19   AAA   734/734
(100 %)
2 diff
(99.8 %id)
BU616087 Bone, Subchondral Bone .a 1375 to 2127 771 to 19   AAA   753/753
(100 %)
2 diff
(99.8 %id)
CU452747 epidermis .a 1384 to 2141 762 to 4     Submitted on the opposite strand 759/762
(99 %)
0 diff
(100 %id)
AI567724 adenocarcinoma, Pancreas .a 1388 to 2110 721 to 1       721/723
(99 %)
19 diff
(97.4 %id)
AW190714 adenocarcinoma, Pancreas .a 1402 to 2107 706 to 1       706/706
(100 %)
13 diff
(98.2 %id)
CU452825 epidermis .a 1403 to 2141 743 to 4     Submitted on the opposite strand 740/743
(99 %)
0 diff
(100 %id)
CX755438 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 1409 to 2180 1 to 759     Submitted on the opposite strand 759/828
(91 %)
15 diff
(98.2 %id)
W95099 liver and spleen .a 1412 to 1786 1 to 372   fully sequenced,   372/372
(100 %)
3 diff
(99.2 %id)
CU450647 epidermis .a 1415 to 2141 731 to 4     Submitted on the opposite strand 728/731
(99 %)
0 diff
(100 %id)
BU676210 lung, Primary Lung Epithelial Cells .a 1420 to 2107 707 to 19   AAA   689/689
(100 %)
1 diff
(99.9 %id)
CU444347 epidermis .a 1427 to 2141 719 to 4     Submitted on the opposite strand 716/719
(99 %)
0 diff
(100 %id)
CU450838 epidermis .a 1430 to 2141 717 to 4     Submitted on the opposite strand 714/720
(99 %)
0 diff
(100 %id)
AI819393 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 1456 to 2131 677 to 2       676/677
(99 %)
0 diff
(100 %id)
AA371353 Prostate .a 1460 to 1669 1 to 210       210/210
(100 %)
0 diff
(100 %id)
BM727581 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1474 to 1976 1 to 503   fully sequenced,   503/503
(100 %)
0 diff
(100 %id)
BM711533 eye, optic nerve .a 1499 to 2104 1 to 606   AAA   606/606
(100 %)
0 diff
(100 %id)
TI_149275021   .a 1504 to 2321 893 to 86   AAA   808/1001
(80 %)
16 diff
(98.5 %id)
CN352572 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1507 to 2302 1 to 791       791/792
(99 %)
6 diff
(99.3 %id)
TI_154113860   .a 1507 to 2333 891 to 85   AAA   807/917
(88 %)
32 diff
(96.6 %id)
TI_149300648   .a 1545 to 2319 862 to 101   AAA   762/931
(81 %)
14 diff
(98.5 %id)
CK430820 eye, lacrimal gland .a 1551 to 2200 1 to 650       650/650
(100 %)
0 diff
(100 %id)
BU629241 cell lines, Chondrosarcoma .a 1563 to 2107 563 to 19   AAA   545/545
(100 %)
0 diff
(100 %id)
CD251549 brain, Pituitary .a 1569 to 2385 1 to 820       820/820
(100 %)
5 diff
(99.4 %id)
AA479703 ovarian tumor, ovary .a 1630 to 2108 478 to 1       478/478
(100 %)
4 diff
(99.2 %id)
BG058487 blood, lymphocyte .a 1631 to 2102 486 to 15   AAA   472/472
(100 %)
0 diff
(100 %id)
BQ574440 Chondrosarcoma Grade II, Left Pelvis .a 1635 to 2312 695 to 19   AAA   677/677
(100 %)
1 diff
(99.9 %id)
CA430661 cell lines, Chondrosarcoma .a 1635 to 2312 694 to 19   AAA   676/676
(100 %)
2 diff
(99.8 %id)
BU629081 cell lines, Chondrosarcoma .a 1642 to 2312 688 to 19   AAA   670/670
(100 %)
2 diff
(99.8 %id)
CB241485 Human Lung Epithelial cells, lung .a 1649 to 2312 680 to 19   AAA   662/662
(100 %)
2 diff
(99.7 %id)
AA971276 Kidney, kidney tumor .a 1658 to 2069 412 to 1       412/412
(100 %)
0 diff
(100 %id)
BU616140 Bone, Subchondral Bone .a 1662 to 2312 669 to 19   AAA   651/651
(100 %)
0 diff
(100 %id)
AW150352 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 1678 to 2107 430 to 1       430/430
(100 %)
0 diff
(100 %id)
AI499177 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 1681 to 2108 428 to 1       428/428
(100 %)
0 diff
(100 %id)
DB509863 testis .a 1682 to 2102 1 to 421     Submitted on the opposite strand 421/421
(100 %)
0 diff
(100 %id)
BM725222 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1697 to 1877 1 to 181   fully sequenced,   181/181
(100 %)
0 diff
(100 %id)
CX164155 human embryonic stem cells differentiated toan early endodermal cell type .a 1701 to 2519 1 to 819       819/819
(100 %)
6 diff
(99.3 %id)
AI312749 lung .a 1702 to 2107 406 to 1       406/406
(100 %)
0 diff
(100 %id)
CB850850 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 1709 to 2319 626 to 16   AAA   611/611
(100 %)
0 diff
(100 %id)
BU676491 lung, Primary Lung Epithelial Cells .a 1720 to 2321 618 to 17   AAA   602/613
(98 %)
0 diff
(100 %id)
CX868108 embryonic stem .a 1733 to 2312 605 to 26   AAA   580/580
(100 %)
4 diff
(99.4 %id)
AA513671 colon .a 1737 to 2102 366 to 1       366/366
(100 %)
0 diff
(100 %id)
AI203533 heart .a 1746 to 2122 377 to 1       377/377
(100 %)
0 diff
(100 %id)
CA448834 Chondrosarcoma, Left Pelvis .a 1750 to 2333 602 to 19   AAA   584/584
(100 %)
0 diff
(100 %id)
W95100 liver and spleen .a 1756 to 2097 336 to 1   fully sequenced,   336/336
(100 %)
2 diff
(99.5 %id)
AW007087 colon .a 1799 to 2113 315 to 1       315/315
(100 %)
0 diff
(100 %id)
AW780064 colon, moderately-differentiated adenocarcinoma .a 1799 to 2102 304 to 1       304/304
(100 %)
0 diff
(100 %id)
CB161215 Liver .a 1815 to 2309 495 to 1     Submitted on the opposite strand 495/495
(100 %)
0 diff
(100 %id)
AA410608 ovarian tumor, ovary .a 1816 to 2114 299 to 1       299/299
(100 %)
0 diff
(100 %id)
AW512955 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 1824 to 2312 504 to 16   AAA   489/489
(100 %)
0 diff
(100 %id)
BM551191 duodenal adenocarcinoma, cell line, small intestine .a 1824 to 2681 1 to 872       872/1169
(74 %)
21 diff
(98.3 %id)
AI828375 adenocarcinoma, Pancreas .a 1844 to 2316 473 to 1       473/473
(100 %)
0 diff
(100 %id)
BM678233 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1847 to 2312 484 to 19   fully sequenced, AAA   466/466
(100 %)
0 diff
(100 %id)
AW057802 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 1868 to 2312 445 to 1       445/445
(100 %)
0 diff
(100 %id)
BM742619 Ascites, stomach .a 1875 to 2107 1 to 233   AAA   233/233
(100 %)
0 diff
(100 %id)
AI582319 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 1886 to 2319 447 to 14   AAA   434/434
(100 %)
0 diff
(100 %id)
AA908353 ovary, serous adenocarcinoma .a 1924 to 2312 407 to 19   AAA   389/389
(100 %)
0 diff
(100 %id)
AI491946 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 1924 to 2127 204 to 1       204/204
(100 %)
0 diff
(100 %id)
AI358214 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 1925 to 2312 436 to 49   AAA   388/388
(100 %)
0 diff
(100 %id)
CK825949 Pancreas, Purified pancreatic islet .a 1932 to 2107 188 to 13   AAA Submitted on the opposite strand 176/176
(100 %)
0 diff
(100 %id)
BM681801 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1946 to 2102 176 to 19   fully sequenced, AAA   158/158
(100 %)
1 diff
(99.4 %id)
AI696414 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 1996 to 2102 107 to 1       107/107
(100 %)
0 diff
(100 %id)
AL534031 brain, fetal brain .a 2125 to 3090 968 to 1       968/968
(100 %)
12 diff
(98.8 %id)
TI_153957323   .a 2326 to 2963 76 to 709   tiling clone,   634/943
(67 %)
5 diff
(99.5 %id)
BU622974 cell lines, Chondrosarcoma .a 2367 to 3103 757 to 19   AAA   739/739
(100 %)
2 diff
(99.8 %id)
AI830967 lymph node, lymphoma, follicular mixed small and largecell .a 2688 to 3106 423 to 3   tiling clone,   421/423
(99 %)
0 diff
(100 %id)
BQ069657 brain, neuroblastoma, cell line .b 1 to 495 1 to 494   tiling clone,   494/1004
(49 %)
7 diff
(99.4 %id)
BQ071700 brain, neuroblastoma, cell line .b 1 to 505 1 to 507       507/1167
(43 %)
18 diff
(98.5 %id)
BM759031 Ascites, stomach .b 8 to 305 1 to 298       298/298
(100 %)
2 diff
(99.4 %id)
BG324087 Kidney, renal cell adenocarcinoma .b 19 to 818 1 to 783       783/810
(96 %)
28 diff
(96.6 %id)
BM737750 Ascites, stomach .b 21 to 485 1 to 465       465/465
(100 %)
9 diff
(98.1 %id)
TI_157600056   .b 26 to 486 526 to 66       461/1119
(41 %)
0 diff
(100 %id)
BQ690693 ductal carcinoma, cell line, Pancreas .b 27 to 486 1 to 460       460/1060
(43 %)
4 diff
(99.7 %id)
BQ685443 ductal carcinoma, cell line, Pancreas .b 27 to 540 1 to 514       514/956
(53 %)
15 diff
(98.5 %id)
BE270331 Burkitt lymphoma, lymph .b 29 to 457 1 to 429       429/429
(100 %)
0 diff
(100 %id)
BF206332 brain, neuroblastoma .b 30 to 727 1 to 688       688/717
(95 %)
13 diff
(98.2 %id)
BI197307 brain, neuroblastoma .b 30 to 873 1 to 851       851/858
(99 %)
36 diff
(95.9 %id)
BG612268 adenocarcinoma, Prostate .b 33 to 839 1 to 822       822/838
(98 %)
27 diff
(96.8 %id)
BU190459 hepatocellular carcinoma, cell line, Liver .b 33 to 917 1 to 906       906/1139
(79 %)
29 diff
(97.5 %id)
BQ650515 hepatocellular carcinoma, cell line, Liver .b 33 to 760 1 to 736       736/947
(77 %)
16 diff
(98.4 %id)
BE463815 pooled germ cell tumors .b 37 to 475 439 to 1       439/439
(100 %)
0 diff
(100 %id)
BF057795 pooled germ cell tumors .b 37 to 486 457 to 8       450/457
(98 %)
0 diff
(100 %id)
BM557781 astrocytoma grade IV, cell line, brain .b 37 to 603 1 to 572       572/1395
(41 %)
18 diff
(98.8 %id)
AW072053 anaplastic oligodendroglioma, brain .b 40 to 447 408 to 1       408/408
(100 %)
0 diff
(100 %id)
AI961043 pooled germ cell tumors .b 41 to 469 429 to 1       429/429
(100 %)
0 diff
(100 %id)
BQ689393 ductal carcinoma, cell line, Pancreas .b 54 to 583 1 to 530       530/1071
(49 %)
3 diff
(99.8 %id)
AI568510 anaplastic oligodendroglioma, brain .b 59 to 469 411 to 1       411/411
(100 %)
1 diff
(99.8 %id)
CN285819 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 60 to 294 1 to 235       235/235
(100 %)
1 diff
(99.6 %id)
AW243347 Kidney .b 60 to 469 410 to 1       410/410
(100 %)
4 diff
(99.1 %id)
AI479909 anaplastic oligodendroglioma, brain .b 62 to 469 408 to 1       408/408
(100 %)
0 diff
(100 %id)
AW005434 anaplastic oligodendroglioma, brain .b 72 to 469 398 to 1       398/398
(100 %)
0 diff
(100 %id)
BF062811 colon, colon tumor, RER+ .b 72 to 477 407 to 2       406/407
(99 %)
0 diff
(100 %id)
BF111610 pooled .b 81 to 486 413 to 8       406/413
(98 %)
0 diff
(100 %id)
AW589687 pooled germ cell tumors .b 92 to 441 350 to 1       350/350
(100 %)
1 diff
(99.8 %id)
AI950423 pooled germ cell tumors .b 93 to 451 359 to 1       359/359
(100 %)
1 diff
(99.8 %id)
BE501155 pooled germ cell tumors .b 93 to 486 401 to 8       394/401
(98 %)
0 diff
(100 %id)
BF592940 pooled germ cell tumors .b 93 to 486 401 to 8       394/401
(98 %)
0 diff
(100 %id)
BG528489 adenocarcinoma, Prostate .b 93 to 792 70 to 773       755/959
(78 %)
33 diff
(96.6 %id)
AW205104   .b 94 to 486 398 to 7       392/399
(98 %)
0 diff
(100 %id)
TI_153988956   .b 94 to 486 455 to 64       392/607
(64 %)
0 diff
(100 %id)
AI824907 pooled germ cell tumors .b 139 to 469 332 to 1       332/333
(99 %)
1 diff
(99.7 %id)
AA932943 pooled .b 166 to 486 326 to 8       319/326
(97 %)
0 diff
(100 %id)
BM561381 amelanotic melanoma, cell line, skin .b 291 to 1104 1 to 817   tiling clone,   817/1083
(75 %)
12 diff
(98.9 %id)
BG477273 melanotic melanoma, skin .b 319 to 1029 1 to 745       665/1069
(62 %)
40 diff
(96.3 %id)
BI160121 epithelioid carcinoma cell line, Pancreas .b 323 to 948 1 to 628   available from MGC,   628/630
(99 %)
7 diff
(98.9 %id)
BC022808 Pancreas, epithelioid carcinoma .b 324 to 1097 1 to 774   tiling clone, available from MGC, AAA   774/774
(100 %)
1 diff
(99.9 %id)
BF026207 melanotic melanoma, skin .b 393 to 938 169 to 724       680/1076
(63 %)
37 diff
(96.6 %id)
AY116620   .c 1 to 1597 1 to 1597 exact tiling clone,   1597/1597
(100 %)
6 diff
(99.7 %id)
TI_57236682   .c 13 to 823 25 to 843 A5G A6G A7G A8G G9W ... tiling clone,   815/895
(91 %)
29 diff
(96.8 %id)
AI684228 serous papillary carcinoma, high grade, 2pooled tumors, uterus .c 1114 to 1681 576 to 9   tiling clone,   568/580
(97 %)
0 diff
(100 %id)
DB139817 thymus .d 1 to 525 8 to 532   tiling clone, capped   531/531
(100 %)
1 diff
(99.9 %id)
DA237317 brain .d 15 to 552 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
AK057133 Spleen .d 423 to 2481 1 to 2059 L5P tiling clone, available from FLJ,   2059/2059
(100 %)
2 diff
(100.0 %id)
DA931394 Spleen .d 424 to 977 2 to 557   capped   556/556
(100 %)
3 diff
(99.5 %id)
CN352586 embryonic stem cells, DMSO-treated H9 cellline .d 584 to 1147 1 to 564       564/564
(100 %)
5 diff
(99.2 %id)
CN352583 embryonic stem cells, cell lines H1, H7, andH9 .d 761 to 1469 6 to 715   tiling clone,   710/715
(99 %)
6 diff
(99.2 %id)
DB332487 Spleen .d 1948 to 2481 535 to 1       535/535
(100 %)
2 diff
(99.7 %id)
DB451267 testis .e -8 to 486 1 to 495   tiling clone,   495/495
(100 %)
1 diff
(99.8 %id)
CN402133 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e 12 to 652 1 to 641   tiling clone,   641/641
(100 %)
1 diff
(99.9 %id)
CN402156 embryonic stem cells, cell lines H1, H7, andH9 .e 22 to 596 1 to 575       575/575
(100 %)
2 diff
(99.7 %id)
DA251760 caudate nucleus .e 570 to 1152 2 to 584   tiling clone, capped   583/583
(100 %)
0 diff
(100 %id)
AK027770 placenta .e 979 to 4060 1 to 3078 exact tiling clone, available from FLJ,   3078/3078
(100 %)
3 diff
(100.0 %id)
DB306392 caudate nucleus .e 2895 to 3421 528 to 1       528/530
(99 %)
1 diff
(99.9 %id)
DC409570 thymus .f 1 to 543 6 to 550   tiling clone,   550/550
(100 %)
2 diff
(99.7 %id)
AK301199 Spleen .f 135 to 1637 1 to 1503 exact tiling clone,   1503/1503
(100 %)
0 diff
(100 %id)
DC390887 Spleen .f 135 to 700 1 to 567       567/567
(100 %)
1 diff
(99.9 %id)
AF251294 Liver .g 1 to 2905 9 to 2929 G8A K9R G10P P11K S12P ... tiling clone, AAA   2891/2929
(98 %)
23 diff
(99.3 %id)
AK000685 ileal mucosa .g 903 to 3693 1 to 2792 exact tiling clone, available from FLJ, AAA   2792/2792
(100 %)
2 diff
(100.0 %id)
BP378303 uterus .g 946 to 1523 1 to 577       577/577
(100 %)
1 diff
(99.9 %id)
BE389654 endometrium, adenocarcinoma cell line, uterus .h 1 to 660 1 to 657       657/660
(99 %)
8 diff
(98.8 %id)
BE390474 endometrium, adenocarcinoma cell line, uterus .h 1 to 607 1 to 605       606/606
(100 %)
29 diff
(95.3 %id)
BE388305 endometrium, adenocarcinoma cell line, uterus .h 1 to 629 1 to 628       628/629
(99 %)
6 diff
(99.1 %id)
BE390616 endometrium, adenocarcinoma cell line, uterus .h 1 to 676 1 to 669   tiling clone,   669/670
(99 %)
13 diff
(98.1 %id)
BE385851 melanotic melanoma, skin .h 1 to 644 1 to 636       636/676
(94 %)
11 diff
(98.4 %id)
BE384924 melanotic melanoma, skin .h 1 to 661 1 to 657       657/663
(99 %)
5 diff
(99.3 %id)
AW136734   .h 199 to 500 302 to 1       302/312
(96 %)
1 diff
(99.7 %id)
AI937632 anaplastic oligodendroglioma, brain .h 200 to 463 264 to 1       264/264
(100 %)
2 diff
(99.3 %id)
AI654366 pooled germ cell tumors .h 232 to 469 238 to 1       238/238
(100 %)
1 diff
(99.6 %id)
AI968787 pooled germ cell tumors .h 232 to 462 231 to 1       231/231
(100 %)
1 diff
(99.6 %id)
AW137409   .h 275 to 500 226 to 1       226/227
(99 %)
5 diff
(97.8 %id)
AI805239 Prostate .h 317 to 483 167 to 1       167/167
(100 %)
0 diff
(100 %id)
BF939219 Prostate .h 317 to 483 167 to 1       167/167
(100 %)
0 diff
(100 %id)
BF221966 Prostate .h 317 to 501 185 to 1       185/185
(100 %)
0 diff
(100 %id)
AA662157 normal prostate, Prostate .h 320 to 469 150 to 1       150/150
(100 %)
0 diff
(100 %id)
TI_154124951   .h 321 to 1105 894 to 127   tiling clone, AAA   768/911
(84 %)
35 diff
(96.2 %id)
AK026796 Human lung .i 1 to 2620 1 to 2620 P213L tiling clone, available from FLJ, AAA   2620/2620
(100 %)
6 diff
(99.8 %id)
BP358686 mammary gland .i 801 to 1382 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BP198074 adrenal gland .j 1 to 582 1 to 582   tiling clone,   582/582
(100 %)
0 diff
(100 %id)
NM_001127230.1   .j 1 to 812 1 to 812 exact RefSeq, AAA   812/812
(100 %)
0 diff
(100 %id)
BE336656 adenocarcinoma cell line, ovary .j 10 to 301 1 to 292       292/292
(100 %)
0 diff
(100 %id)
BQ927531 carcinoma, cell line, Prostate .j 14 to 811 1 to 798   tiling clone, AAA   798/798
(100 %)
6 diff
(99.3 %id)
DN994953 brain, whole brain .j 19 to 584 9 to 574       566/574
(98 %)
6 diff
(99.0 %id)
BG481188 choriocarcinoma, placenta .j 24 to 493 1 to 470       470/470
(100 %)
0 diff
(100 %id)
BG481112 choriocarcinoma, placenta .j 24 to 767 1 to 802       738/835
(88 %)
70 diff
(91.7 %id)
DB453871 testis .j 27 to 517 1 to 491       491/491
(100 %)
0 diff
(100 %id)
BE903314 choriocarcinoma, placenta .j 27 to 800 11 to 784   tiling clone,   774/784
(98 %)
9 diff
(98.9 %id)
BF590595 colon, colon tumor, RER+ .j 47 to 194 146 to 1       146/146
(100 %)
2 diff
(98.7 %id)
BX109450 lung .k 1 to 806 1 to 806 R239X tiling clone,   806/806
(100 %)
1 diff
(99.9 %id)
AK056120   .l 1 to 2812 4 to 2814 Q167* tiling clone, available from FLJ,   2814/2814
(100 %)
3 diff
(99.9 %id)
CN402143 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .l 4 to 722 1 to 719       719/719
(100 %)
0 diff
(100 %id)
BQ897146 dorsal root ganglia .l 111 to 1043 1 to 939   tiling clone,   939/939
(100 %)
27 diff
(97.2 %id)
BM787731 stomach .l 336 to 991 1 to 657       657/657
(100 %)
1 diff
(99.9 %id)
BX460792 brain, fetal brain .l 980 to 1739 1 to 759       759/759
(100 %)
1 diff
(99.9 %id)
BQ881172 dorsal root ganglia .l 1053 to 1812 1 to 773       773/856
(90 %)
26 diff
(97.0 %id)
CD514347 White Matter .l 1150 to 2037 31 to 927   tiling clone,   897/927
(96 %)
25 diff
(97.4 %id)
CA975952 sciatic nerve .l 1164 to 1910 1 to 757       757/905
(83 %)
8 diff
(99.2 %id)
AK292268 testis .l 1172 to 2570 1 to 1399       1399/1399
(100 %)
0 diff
(100 %id)
BP225526   .l 1187 to 1768 1 to 581       581/581
(100 %)
4 diff
(99.4 %id)
DA734139   .l 1191 to 1752 2 to 565   capped   564/566
(99 %)
6 diff
(99.0 %id)
BF343987 brain, glioblastoma with EGFR amplification .l 1246 to 1863 1 to 615       615/615
(100 %)
4 diff
(99.4 %id)
BM472899 duodenal adenocarcinoma, cell line, small intestine .l 1266 to 2149 1 to 891       891/1014
(87 %)
14 diff
(98.7 %id)
BP367272 thymus .l 1271 to 1843 1 to 573       573/573
(100 %)
0 diff
(100 %id)
DA837979 placenta .l 1285 to 1835 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
DT219002 brain .l 1294 to 1930 1 to 637       637/637
(100 %)
0 diff
(100 %id)
BC071622 Bone, osteosarcoma .l 1308 to 3017 1 to 1710   tiling clone, available from MGC, AAA   1710/1710
(100 %)
1 diff
(100.0 %id)
BG113613 Bone, osteosarcoma, cell line .l 1308 to 2031 1 to 720   available from MGC,   720/924
(77 %)
11 diff
(98.9 %id)
BQ638980 eye, retina .l 1317 to 1927 1 to 611       611/611
(100 %)
0 diff
(100 %id)
CX867991 embryonic stem .l 1360 to 2091 1 to 732       732/732
(100 %)
0 diff
(100 %id)
BX413250 brain, fetal brain .l 1936 to 2804 867 to 2       866/884
(97 %)
0 diff
(100 %id)
CX867915 embryonic stem .l 2181 to 2812 659 to 28   AAA   632/632
(100 %)
6 diff
(99.1 %id)
NM_001039577.3   .m -10 to 1196 1 to 1207 exact RefSeq, AAA   1207/1207
(100 %)
0 diff
(100 %id)
TI_44165852   .m 1 to 802 125 to 928 L77I D166G Q167S D168R Y169L ...     811/928
(87 %)
19 diff
(98.0 %id)
BI545841 brain, hippocampus .m 1 to 802 5 to 808 L77I D166G Q167S D168R Y169L ... tiling clone,   808/808
(100 %)
18 diff
(97.8 %id)
TI_57199098   .m 1 to 876 65 to 939 exact     876/939
(93 %)
21 diff
(97.8 %id)
BC016333 Brain, primitive neuroectodermal .m 10 to 1196 1 to 1187 T71S available from MGC, AAA   1187/1187
(100 %)
3 diff
(99.8 %id)
BU163481 ductal carcinoma, cell line, Pancreas .m 14 to 806 22 to 818 K158R K159S V161C P162L L163Y ...     797/942
(84 %)
24 diff
(97.5 %id)
AL834441 amygdala .m 59 to 2356 1 to 2298   tiling clone, available from DKFZ, AAA   2298/2298
(100 %)
0 diff
(100 %id)
CB243810 Human Lung Epithelial cells, lung .m 483 to 1190 726 to 19   AAA   708/708
(100 %)
1 diff
(99.9 %id)
BI793110 Islets of Langerhans, Pancreas .m 577 to 711 1 to 135   fully sequenced,   135/135
(100 %)
0 diff
(100 %id)
BI793263 Islets of Langerhans, Pancreas .m 577 to 942 1 to 365   fully sequenced,   365/365
(100 %)
0 diff
(100 %id)
CA444777 lung, Metastatic Chondrosarcoma .m 579 to 1190 630 to 19   AAA   612/635
(96 %)
0 diff
(100 %id)
AI590186 Kidney .m 588 to 1192 613 to 9       605/613
(98 %)
0 diff
(100 %id)
BI792847 Islets of Langerhans, Pancreas .m 650 to 1190 558 to 18   fully sequenced, AAA   541/541
(100 %)
0 diff
(100 %id)
BI792970 Islets of Langerhans, Pancreas .m 912 to 1190 296 to 18   fully sequenced, AAA   279/279
(100 %)
0 diff
(100 %id)
AK074112 Spleen .n 1 to 4451 2 to 4452 exact tiling clone, available from FLJ,   4452/4452
(100 %)
0 diff
(100 %id)
BU190974 ductal carcinoma, cell line, Pancreas .n 1 to 857 2 to 863 exact     863/866
(99 %)
26 diff
(97.0 %id)
CX785792 human embryonic stem cells .n 1 to 860 2 to 861 exact     861/861
(100 %)
1 diff
(99.9 %id)
BX422194 fetal liver, Liver .n 11 to 1056 1 to 1042       1042/1042
(100 %)
11 diff
(99.0 %id)
CR599231 Neuroblastoma Cot 25-normalized .n 17 to 1118 1 to 1102       1102/1102
(100 %)
0 diff
(100 %id)
CN352590 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .n 28 to 758 1 to 731       731/731
(100 %)
1 diff
(99.9 %id)
DB060773 testis .n 114 to 685 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
DA437897 tongue, tumor tissue .n 140 to 700 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
BP421347 small intestine .n 185 to 688 1 to 505     Submitted on the opposite strand 504/505
(99 %)
6 diff
(98.9 %id)
DB234314 trachea .n 205 to 721 2 to 518   capped   517/517
(100 %)
1 diff
(99.9 %id)
BE564330 bladder, carcinoma, cell line .n 259 to 918 1 to 644       644/873
(73 %)
26 diff
(97.1 %id)
DA810369 brain .n 363 to 897 2 to 536   capped   535/535
(100 %)
0 diff
(100 %id)
DA098926 cerebellum .n 397 to 938 2 to 544   capped   543/543
(100 %)
1 diff
(99.9 %id)
DA803521 brain .n 406 to 956 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
BE770503 prostate_tumor .n 408 to 1038 10 to 640       631/640
(98 %)
7 diff
(99.0 %id)
BE770437 prostate_tumor .n 410 to 1042 1 to 627       627/653
(96 %)
15 diff
(97.8 %id)
BE716063 head_neck .n 412 to 1045 1 to 633       633/633
(100 %)
6 diff
(99.1 %id)
BE716071 head_neck .n 412 to 1038 1 to 626       626/626
(100 %)
8 diff
(98.8 %id)
BE836421 prostate_normal .n 414 to 988 6 to 579       574/579
(99 %)
8 diff
(98.7 %id)
BF372657 prostate_tumor .n 415 to 975 1 to 562       562/573
(98 %)
24 diff
(95.9 %id)
DA211319 brain .n 416 to 973 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
BE770494 prostate_tumor .n 417 to 960 3 to 547       545/547
(99 %)
8 diff
(98.6 %id)
BE817030 breast_normal .n 417 to 1016 5 to 602       598/608
(98 %)
21 diff
(96.6 %id)
BE770447 prostate_tumor .n 426 to 1067 1 to 639       639/641
(99 %)
9 diff
(98.6 %id)
DA446299 tongue, tumor tissue .n 438 to 1005 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
CR987973 T-Lymphocytes .n 447 to 1350 1 to 904       904/904
(100 %)
5 diff
(99.5 %id)
DA221291 brain .n 461 to 1028 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
BE716072 head_neck .n 467 to 1110 649 to 6       644/649
(99 %)
0 diff
(100 %id)
DA241237 brain .n 482 to 1055 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
BE716055 head_neck .n 493 to 1105 619 to 7       613/619
(99 %)
0 diff
(100 %id)
DA236064 brain .n 511 to 1097 2 to 589   capped   588/588
(100 %)
1 diff
(99.9 %id)
DB283456 uterus .n 515 to 1057 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DB134290 thymus .n 517 to 1066 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA126801 cerebellum .n 534 to 1125 2 to 593   capped   592/592
(100 %)
0 diff
(100 %id)
CA390164 eye, RPE/choroid .n 546 to 1165 1 to 620       620/620
(100 %)
0 diff
(100 %id)
DB290949 uterus .n 555 to 1130 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
EL595185 epidermis, skin .n 599 to 1329 753 to 19     Submitted on the opposite strand 735/754
(97 %)
3 diff
(99.7 %id)
DA099694 cerebellum .n 609 to 1158 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA438093 tongue, tumor tissue .n 691 to 1238 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
DA070499 cerebellum .n 696 to 1253 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA092192 cerebellum .n 716 to 1296 2 to 583   capped   582/582
(100 %)
1 diff
(99.9 %id)
AA323816 brain, cerebellum .n 732 to 1019 1 to 287       287/287
(100 %)
1 diff
(99.7 %id)
AW961993   .n 733 to 1281 1 to 546       546/546
(100 %)
11 diff
(98.0 %id)
DA214738 brain .n 744 to 1256 2 to 515   capped   514/514
(100 %)
1 diff
(99.9 %id)
BF372662 prostate_tumor .n 749 to 1049 306 to 4       303/325
(93 %)
0 diff
(100 %id)
BX410103 fetal liver, Liver .n 756 to 1681 1 to 922       922/922
(100 %)
9 diff
(99.1 %id)
BY798994 eye .n 786 to 1316 1 to 531       531/531
(100 %)
0 diff
(100 %id)
DA408780 thalamus .n 803 to 1467 2 to 665   capped   664/664
(100 %)
2 diff
(99.7 %id)
DR980040 placenta .n 804 to 966 1 to 162   AAA Submitted on the opposite strand 162/162
(100 %)
7 diff
(95.7 %id)
CN402157 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .n 810 to 1397 1 to 588       588/588
(100 %)
0 diff
(100 %id)
BE817029 breast_normal .n 815 to 1110 1 to 294       294/302
(97 %)
9 diff
(97.1 %id)
BF372656 prostate_tumor .n 846 to 1110 296 to 25       272/296
(91 %)
0 diff
(100 %id)
DA094836 cerebellum .n 847 to 1325 2 to 480   capped   479/479
(100 %)
1 diff
(99.8 %id)
CN402137 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .n 874 to 1580 1 to 708       708/708
(100 %)
3 diff
(99.6 %id)
EC454135 Prostate .n 875 to 989 114 to 1       114/114
(100 %)
1 diff
(99.2 %id)
AA150214 uterus .n 886 to 1171 288 to 1       288/293
(98 %)
5 diff
(98.3 %id)
CB137508 Liver .n 898 to 1459 1 to 562       562/562
(100 %)
0 diff
(100 %id)
CN402153 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .n 901 to 1226 1 to 326       326/326
(100 %)
0 diff
(100 %id)
BF372669 prostate_tumor .n 903 to 1109 217 to 8       210/220
(95 %)
0 diff
(100 %id)
AW874335 Pancreas .n 912 to 1178 269 to 2       268/269
(99 %)
0 diff
(100 %id)
DA068975 cerebellum .n 913 to 1454 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
DR760063 embryonic stem .n 936 to 1657 1 to 722       722/722
(100 %)
0 diff
(100 %id)
DA806483 brain .n 940 to 1503 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
DA797890 brain .n 945 to 1492 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
DA455654 tongue, tumor tissue .n 957 to 1528 2 to 575   capped   574/574
(100 %)
2 diff
(99.7 %id)
DA380904 thalamus .n 982 to 1623 2 to 644   capped   643/643
(100 %)
1 diff
(99.9 %id)
DA185186 amygdala .n 999 to 1562 2 to 567   capped   566/566
(100 %)
2 diff
(99.7 %id)
CK430928 eye, lacrimal gland .n 1008 to 1652 1 to 645       645/645
(100 %)
2 diff
(99.7 %id)
BQ373204 prostate_tumor .n 1009 to 1110 123 to 20       104/123
(84 %)
0 diff
(100 %id)
CN402139 embryonic stem cells, cell lines H1, H7, andH9 .n 1025 to 1685 1 to 664       664/664
(100 %)
4 diff
(99.4 %id)
DB129993 thymus .n 1032 to 1605 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DB130635 thymus .n 1033 to 1564 2 to 533   capped   532/532
(100 %)
0 diff
(100 %id)
DA734921   .n 1038 to 1709 2 to 679   capped   678/682
(99 %)
17 diff
(97.6 %id)
CN402140 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .n 1041 to 1676 1 to 636       636/636
(100 %)
2 diff
(99.7 %id)
BF869659 lung_tumor .n 1044 to 1357 314 to 1     Submitted on the opposite strand 314/314
(100 %)
0 diff
(100 %id)
BF870053 lung_tumor .n 1044 to 1357 314 to 1     Submitted on the opposite strand 314/314
(100 %)
0 diff
(100 %id)
AA708784 uterus .n 1045 to 1171 127 to 1       127/127
(100 %)
0 diff
(100 %id)
DA443432 tongue, tumor tissue .n 1115 to 1642 2 to 530   capped   529/529
(100 %)
1 diff
(99.9 %id)
DB121967 thymus .n 1117 to 1670 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
DB148519 thymus .n 1118 to 1661 2 to 546   capped   545/545
(100 %)
1 diff
(99.9 %id)
CA423503 cell lines, Chondrosarcoma .n 1134 to 1833 719 to 19   AAA   701/701
(100 %)
4 diff
(99.5 %id)
DA558906   .n 1151 to 1701 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
TI_154033675   .n 1180 to 1851 36 to 707   AAA Submitted on the opposite strand 672/707
(95 %)
6 diff
(99.2 %id)
DA944629 Spleen .n 1197 to 1758 2 to 564   capped   563/563
(100 %)
3 diff
(99.5 %id)
DB087852 testis .n 1201 to 1747 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
CN402138 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .n 1231 to 1890 1 to 660       660/660
(100 %)
0 diff
(100 %id)
BJ993051 hepatoblastoma .n 1242 to 1753 1 to 512       512/512
(100 %)
0 diff
(100 %id)
BX339381 Placenta Cot 25-normalized .n 1253 to 2291 1 to 1018       1018/1032
(98 %)
43 diff
(95.9 %id)
DB274341 uterus .n 1267 to 1818 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DB117996 thymus .n 1279 to 1583 2 to 306   capped   305/305
(100 %)
0 diff
(100 %id)
DA469847   .n 1370 to 1947 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DB129650 thymus .n 1375 to 1904 2 to 531   capped   530/530
(100 %)
0 diff
(100 %id)
Z42901 brain, total brain .n 1406 to 1689 1 to 284       284/284
(100 %)
0 diff
(100 %id)
DB271567 uterus .n 1412 to 1973 2 to 565   capped   564/564
(100 %)
2 diff
(99.7 %id)
DA370930 thalamus .n 1451 to 2001 2 to 553   capped   552/552
(100 %)
2 diff
(99.7 %id)
CK430180 eye, lacrimal gland .n 1495 to 1645 1 to 151       151/151
(100 %)
0 diff
(100 %id)
DB019411 esophageal, tumor tissue .n 1495 to 2069 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
CN402142 embryonic stem cells, cell lines H1, H7, andH9 .n 1541 to 2113 1 to 573       573/573
(100 %)
0 diff
(100 %id)
DA570150 whole embryo, mainly head .n 1588 to 2279 2 to 693   capped   692/692
(100 %)
0 diff
(100 %id)
DA046496 bladder .n 1590 to 2066 2 to 478   capped   477/477
(100 %)
0 diff
(100 %id)
DA554441   .n 1590 to 2005 2 to 417   capped   416/416
(100 %)
0 diff
(100 %id)
CN402150 embryonic stem cells, DMSO-treated H9 cellline .n 1613 to 2257 1 to 645       645/645
(100 %)
2 diff
(99.7 %id)
CN402144 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .n 1649 to 2318 1 to 672       672/672
(100 %)
2 diff
(99.8 %id)
BP345644 synovial membrane .n 1670 to 2233 1 to 564       564/564
(100 %)
2 diff
(99.7 %id)
BP353594   .n 1674 to 2259 1 to 584       584/584
(100 %)
3 diff
(99.5 %id)
DA174469 amygdala .n 1682 to 2255 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
DB270370 uterus .n 1692 to 2256 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
BP292815 lung .n 1710 to 2291 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
DA027713   .n 1722 to 2288 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DB004786 breast, tumor tissue .n 1739 to 2305 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA269913 caudate nucleus .n 1747 to 2309 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
BP292854 lung .n 1751 to 2332 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
AA053357 eye, retina .n 1766 to 2097 1 to 334       334/341
(97 %)
12 diff
(96.5 %id)
BP373076 umbilical cord .n 1790 to 2371 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BP198438 adrenal gland .n 1809 to 2396 1 to 587       587/587
(100 %)
1 diff
(99.9 %id)
DA054819 cerebellum .n 1809 to 2373 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
DB185287 liver, tumor tissue .n 1810 to 2390 2 to 583   capped   582/582
(100 %)
1 diff
(99.9 %id)
DA921393 small intestine .n 1817 to 2373 2 to 559   capped   558/559
(99 %)
5 diff
(99.2 %id)
DB104984 thymus .n 1818 to 2368 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DB263771 uterus .n 1818 to 2410 2 to 594   capped   593/593
(100 %)
2 diff
(99.7 %id)
DA919724 small intestine .n 1820 to 2374 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
AI767544 Kidney .n 1830 to 2336 507 to 1       507/507
(100 %)
0 diff
(100 %id)
CK431125 eye, lacrimal gland .n 1842 to 2461 1 to 619       619/619
(100 %)
1 diff
(99.9 %id)
DA938158 Spleen .n 1842 to 2428 2 to 592   capped   591/591
(100 %)
4 diff
(99.4 %id)
BP344750 synovial membrane .n 1864 to 2430 1 to 566       566/566
(100 %)
4 diff
(99.3 %id)
DB244902 uterus, tumor tissue .n 1874 to 2435 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA943871 Spleen .n 1883 to 2455 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
TI_2194696695   .n 1885 to 2906 1170 to 151       1020/1292
(78 %)
27 diff
(98.0 %id)
DA877323 Prostate .n 1888 to 2456 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DB105691 thymus .n 1895 to 2441 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
DA966367 stomach .n 1896 to 2459 2 to 567   capped   566/566
(100 %)
2 diff
(99.7 %id)
BX644881   .n 1905 to 2372 1 to 468       468/468
(100 %)
0 diff
(100 %id)
DA486465 brain .n 1905 to 2478 2 to 574   capped   573/573
(100 %)
2 diff
(99.7 %id)
DA967646 stomach .n 1906 to 2460 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
CN402145 embryonic stem cells, DMSO-treated H9 cellline .n 1914 to 2627 1 to 717       717/717
(100 %)
4 diff
(99.5 %id)
DB248623 uterus .n 1983 to 2541 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
DA119311 cerebellum .n 1984 to 2518 2 to 536   capped   535/535
(100 %)
2 diff
(99.7 %id)
DB109443 thymus .n 1984 to 2566 2 to 583   capped   582/582
(100 %)
1 diff
(99.9 %id)
DA089474 cerebellum .n 1986 to 2560 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
DB112607 thymus .n 1986 to 2572 2 to 588   capped   587/587
(100 %)
0 diff
(100 %id)
CD723388 eye, lacrimal gland .n 2012 to 2629 1 to 616       616/616
(100 %)
1 diff
(99.9 %id)
CD723454 eye, lacrimal gland .n 2012 to 2642 1 to 629       629/629
(100 %)
2 diff
(99.7 %id)
DB274909 uterus .n 2026 to 2560 2 to 537   capped   536/539
(99 %)
3 diff
(99.5 %id)
Z39028 brain, total brain .n 2035 to 2337 303 to 1       303/303
(100 %)
0 diff
(100 %id)
CX761565 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .n 2035 to 2800 1 to 756     Submitted on the opposite strand 756/771
(98 %)
14 diff
(98.2 %id)
DA955726 Spleen .n 2038 to 2600 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA956626 Spleen .n 2049 to 2593 2 to 547   capped   546/546
(100 %)
3 diff
(99.5 %id)
DB127919 thymus .n 2061 to 2621 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
BI913250 brain .n 2097 to 2805 1 to 714       714/714
(100 %)
11 diff
(98.5 %id)
TI_57240437   .n 2097 to 2805 37 to 750       714/750
(95 %)
14 diff
(98.2 %id)
DA521802 brain .n 2170 to 2724 2 to 556   capped   555/555
(100 %)
2 diff
(99.7 %id)
DA831937 placenta .n 2170 to 2927 2 to 765   capped   764/770
(99 %)
16 diff
(98.0 %id)
BU529089 epidermoid carcinoma, cell line, lung .n 2210 to 2949 1 to 748       748/909
(82 %)
7 diff
(99.3 %id)
DB140964 thymus .n 2226 to 2753 2 to 529   capped   528/528
(100 %)
4 diff
(99.3 %id)
DA061629 cerebellum .n 2233 to 2808 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
DA287137 corpus callosum .n 2233 to 2788 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA879446 Prostate .n 2233 to 2795 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA843056 placenta .n 2249 to 2826 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
DB016633 esophageal, tumor tissue .n 2250 to 2794 2 to 547   capped   546/548
(99 %)
3 diff
(99.5 %id)
DB018591 esophageal, tumor tissue .n 2257 to 2834 2 to 579   capped   578/578
(100 %)
2 diff
(99.7 %id)
AW663189 2 pooled high-grade transitional celltumors, genitourinary tract .n 2288 to 2568 1 to 283       283/283
(100 %)
2 diff
(99.3 %id)
BF433981 fibrotheoma, ovary .n 2290 to 2754 465 to 1       465/465
(100 %)
0 diff
(100 %id)
BX478062   .n 2291 to 2855 1 to 566       566/566
(100 %)
3 diff
(99.5 %id)
DA690939   .n 2306 to 2884 2 to 581   capped   580/580
(100 %)
1 diff
(99.9 %id)
DA962882 stomach .n 2311 to 2867 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA870043 Prostate .n 2319 to 2870 2 to 554   capped   553/553
(100 %)
1 diff
(99.9 %id)
BP346272 synovial membrane .n 2329 to 2911 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BP342808 stomach mucosa .n 2331 to 2912 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BP383324 ilea mucosa .n 2370 to 2925 1 to 556       556/556
(100 %)
0 diff
(100 %id)
DA272283 caudate nucleus .n 2376 to 2832 2 to 458   capped   457/457
(100 %)
0 diff
(100 %id)
DA867160 Prostate .n 2382 to 2913 2 to 534   capped   533/533
(100 %)
1 diff
(99.9 %id)
DC395713 testis .n 2386 to 2929 1 to 545       545/545
(100 %)
1 diff
(99.9 %id)
BP279003   .n 2428 to 3009 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
R85147 brain .n 2435 to 2823 1 to 389       389/391
(99 %)
5 diff
(98.8 %id)
BX339380 Placenta Cot 25-normalized .n 3209 to 4214 1001 to 9       995/1201
(82 %)
27 diff
(97.8 %id)
DB377855 placenta .n 3848 to 4331 480 to 1       480/480
(100 %)
11 diff
(97.8 %id)
DB356891 whole embryo, mainly head .n 3886 to 4447 557 to 1       557/558
(99 %)
15 diff
(97.4 %id)
DB367077   .n 3907 to 4451 546 to 1       546/547
(99 %)
9 diff
(98.4 %id)
AW613633 2 pooled high-grade transitional celltumors, genitourinary tract .n 3987 to 4242 269 to 18   AAA   252/252
(100 %)
2 diff
(99.3 %id)
AA054634 eye, retina .n 3996 to 4447 476 to 22   AAA   455/455
(100 %)
7 diff
(98.5 %id)
R85094 brain .n 4139 to 4441 320 to 15       306/320
(95 %)
0 diff
(100 %id)
BQ072820 leukocyte .o 1 to 923 14 to 945 A2S tiling clone,   932/1067
(87 %)
39 diff
(96.4 %id)
DA944374 Spleen .o 233 to 785 2 to 554   capped   553/553
(100 %)
1 diff
(99.9 %id)
CN402151 embryonic stem cells, cell lines H1, H7, andH9 .o 734 to 1447 1 to 715   tiling clone,   715/715
(100 %)
1 diff
(99.9 %id)
BQ721436 sympathetic trunk .o 826 to 1518 1 to 695   tiling clone,   695/950
(73 %)
18 diff
(98.2 %id)
DN994809 brain, whole brain .o 989 to 1387 1 to 399       399/399
(100 %)
6 diff
(98.5 %id)
BX400637   .p 1 to 800 54 to 853 L32X V76W A77P M78W A79L ... tiling clone,   800/853
(93 %)
10 diff
(98.9 %id)
BM172454 brain, hippocampus .q 1 to 453 7 to 459   tiling clone,   459/459
(100 %)
4 diff
(99.2 %id)
BI551746 brain, hippocampus .q 1 to 851 7 to 901 R12M A13G V14R P15S W16L ...     900/903
(99 %)
88 diff
(90.3 %id)
NM_001127229.1   .q 2 to 910 1 to 909 exact RefSeq, AAA   909/909
(100 %)
0 diff
(100 %id)
BM761974 myeloma .q 2 to 572 1 to 571       571/571
(100 %)
0 diff
(100 %id)
BM839830 myeloma .q 2 to 515 1 to 514       514/514
(100 %)
3 diff
(99.5 %id)
BM841918 myeloma .q 2 to 408 1 to 407       407/407
(100 %)
1 diff
(99.8 %id)
BM846322 myeloma .q 2 to 570 1 to 569       569/569
(100 %)
0 diff
(100 %id)
BM781908 myeloma .q 2 to 514 1 to 513       513/513
(100 %)
0 diff
(100 %id)
AW137226   .q 19 to 292 279 to 7       273/284
(96 %)
2 diff
(99.3 %id)
BF307313 muscle, rhabdomyosarcoma .q 19 to 817 1 to 777       777/791
(98 %)
39 diff
(95.1 %id)
CB991845 placenta, pre-eclamptic placenta .q 20 to 625 28 to 640       613/835
(73 %)
24 diff
(97.2 %id)
BF979203 melanotic melanoma, high MDR, skin .q 21 to 683 1 to 652       652/652
(100 %)
15 diff
(97.7 %id)
BG332744 large cell carcinoma, lung .q 22 to 701 1 to 677       677/900
(75 %)
19 diff
(97.9 %id)
DB449244 testis .q 27 to 436 1 to 411       411/420
(97 %)
2 diff
(99.6 %id)
AA126364 uterus .q 27 to 236 1 to 210   fully sequenced,   210/210
(100 %)
10 diff
(95.3 %id)
BE387106 melanotic melanoma, skin .q 27 to 726 9 to 702       694/780
(88 %)
16 diff
(98.0 %id)
BU146851 brain, neuroblastoma, cell line .q 29 to 903 1 to 883 R155E R174E A185T K193Q I194D ...     883/903
(97 %)
23 diff
(97.5 %id)
BQ882368 brain, neuroblastoma, cell line .q 29 to 737 1 to 711       711/924
(76 %)
8 diff
(99.2 %id)
BE410384 choriocarcinoma, placenta .q 33 to 737 1 to 705       705/778
(90 %)
14 diff
(98.3 %id)
BM695908 eye, human retina .q 34 to 289 1 to 256       256/256
(100 %)
0 diff
(100 %id)
BG621122 placenta .q 35 to 802 1 to 766       766/775
(98 %)
11 diff
(98.6 %id)
BQ939663 eye, normal pigmented retinal epithelium .q 36 to 743 3 to 712       710/970
(73 %)
21 diff
(97.9 %id)
BU553401 ovary, teratocarcinoma, cell line .q 36 to 596 25 to 586       562/1046
(53 %)
16 diff
(98.5 %id)
BI197453 brain, neuroblastoma .q 37 to 900 1 to 873 Y101*     873/888
(98 %)
21 diff
(97.7 %id)
AI420238 Prostate .q 40 to 275 236 to 1       236/236
(100 %)
0 diff
(100 %id)
BE855994 Prostate .q 40 to 292 260 to 8       253/260
(97 %)
0 diff
(100 %id)
BM796743 Ascites, stomach .q 40 to 494 1 to 455       455/455
(100 %)
5 diff
(99.0 %id)
BU151228 brain, neuroblastoma, cell line .q 44 to 735 1 to 695       695/901
(77 %)
6 diff
(99.4 %id)
BQ957091 carcinoma, cell line, Prostate .q 47 to 650 1 to 606       606/1013
(59 %)
16 diff
(98.5 %id)
BF000282 colon, colon tumor, RER+ .q 48 to 291 243 to 1       243/243
(100 %)
1 diff
(99.6 %id)
BF689854 melanotic melanoma, high MDR (cell line), skin .q 49 to 265 1 to 217   fully sequenced,   217/217
(100 %)
0 diff
(100 %id)
BI092260 cervix .q 49 to 289 7 to 247   available from MGC,   241/247
(97 %)
6 diff
(97.6 %id)
BE902889 choriocarcinoma, placenta .q 50 to 731 28 to 719       655/725
(90 %)
32 diff
(95.6 %id)
BC035595 Placenta, choriocarcinoma .q 51 to 291 22 to 261   available from MGC,   240/240
(100 %)
0 diff
(100 %id)
BF739866 Kidney .q 52 to 281 230 to 1       230/230
(100 %)
0 diff
(100 %id)
BF314281 brain, neuroblastoma .q 52 to 795 1 to 730       730/879
(83 %)
28 diff
(96.9 %id)
AI656029 pooled germ cell tumors .q 53 to 275 223 to 1       223/223
(100 %)
0 diff
(100 %id)
AI767282 Kidney .q 53 to 275 223 to 1       223/223
(100 %)
1 diff
(99.6 %id)
AW515722 pooled germ cell tumors .q 53 to 247 195 to 1       195/195
(100 %)
0 diff
(100 %id)
BG475637 melanotic melanoma, skin .q 54 to 857 1 to 808 S50L L51S P52L R53A K54R ...     808/999
(80 %)
31 diff
(96.9 %id)
CD513071 brain, Pituitary .q 54 to 291 1 to 238       238/238
(100 %)
0 diff
(100 %id)
BM053058 Islets of Langerhans, Pancreas .q 55 to 291 1 to 236   fully sequenced,   236/236
(100 %)
0 diff
(100 %id)
BF689503 melanotic melanoma, high MDR (cell line), skin .q 56 to 869 1 to 813 P105A N129K V130R L131A K132*     813/1002
(81 %)
31 diff
(97.0 %id)
BG769944 melanotic melanoma, high MDR (cell line), skin .q 56 to 910 1 to 867 A43V G44R G46R R47*     867/888
(97 %)
26 diff
(97.1 %id)
BG491146 large cell carcinoma, lung .q 59 to 796 1 to 739       739/740
(99 %)
2 diff
(99.8 %id)
AW614611 Kidney .q 61 to 275 215 to 1       215/215
(100 %)
0 diff
(100 %id)
BQ654322 hepatocellular carcinoma, cell line, Liver .q 61 to 624 1 to 573       573/1118
(51 %)
23 diff
(98.0 %id)
AI420881 Prostate .q 62 to 275 214 to 1       214/214
(100 %)
0 diff
(100 %id)
AW136158   .q 62 to 292 237 to 7       231/244
(94 %)
0 diff
(100 %id)
AW590095 pooled germ cell tumors .q 62 to 247 186 to 1       186/186
(100 %)
0 diff
(100 %id)
BE260611 brain, neuroblastoma .q 62 to 767 1 to 708       708/709
(99 %)
6 diff
(99.2 %id)
BF222977 pooled germ cell tumors .q 62 to 292 237 to 8       230/237
(97 %)
1 diff
(99.6 %id)
BQ647716 hepatocellular carcinoma, cell line, Liver .q 62 to 669 20 to 628       609/1039
(58 %)
32 diff
(97.0 %id)
BF063151 colon, colon tumor, RER+ .q 63 to 292 234 to 6       229/234
(97 %)
4 diff
(98.3 %id)
BE251708 eye, retinoblastoma .q 64 to 743 1 to 676       676/723
(93 %)
10 diff
(98.7 %id)
BE252182 eye, retinoblastoma .q 64 to 606 1 to 554       550/554
(99 %)
11 diff
(98.1 %id)
BG764130 melanotic melanoma, high MDR (cell line), skin .q 64 to 873 1 to 810 exact     810/814
(99 %)
3 diff
(99.7 %id)
AW051726 Kidney .q 65 to 275 211 to 1       211/211
(100 %)
0 diff
(100 %id)
BE466495 Kidney .q 65 to 292 235 to 8       228/235
(97 %)
0 diff
(100 %id)
BE464085 pooled germ cell tumors .q 65 to 281 217 to 1       217/217
(100 %)
0 diff
(100 %id)
AA887699 colon, colon tumor RER+ .q 66 to 274 205 to 1       205/205
(100 %)
11 diff
(94.7 %id)
BG334334 melanotic melanoma, skin .q 66 to 737 1 to 682       682/1038
(65 %)
35 diff
(96.7 %id)
BQ648270 hepatocellular carcinoma, cell line, Liver .q 66 to 710 1 to 647       647/967
(66 %)
23 diff
(97.7 %id)
BQ648436 hepatocellular carcinoma, cell line, Liver .q 66 to 900 1 to 837 K168N D172E L178A K179E K193Q ...     837/962
(87 %)
25 diff
(97.5 %id)
BU543859 carcinoma, cell line, Prostate .q 66 to 740 1 to 674       674/951
(70 %)
23 diff
(97.6 %id)
BF062481 colon, colon tumor, RER+ .q 67 to 292 233 to 8       226/233
(96 %)
0 diff
(100 %id)
BQ948079 eye, normal pigmented retinal epithelium .q 67 to 735 36 to 710       675/1032
(65 %)
29 diff
(97.2 %id)
AI199450 anaplastic oligodendroglioma, brain .q 68 to 275 208 to 1       208/208
(100 %)
0 diff
(100 %id)
TI_149313946   .q 68 to 903 916 to 88 exact AAA   829/977
(84 %)
18 diff
(98.2 %id)
BM042133 melanotic melanoma, cell line, skin .q 71 to 530 1 to 460   fully sequenced,   460/460
(100 %)
0 diff
(100 %id)
BM041981 melanotic melanoma, cell line, skin .q 71 to 292 1 to 222   fully sequenced,   222/222
(100 %)
1 diff
(99.6 %id)
BU856918 adenocarcinoma, cell line, breast .q 72 to 645 1 to 578       578/1130
(51 %)
12 diff
(99.0 %id)
BE386571 melanotic melanoma, skin .q 73 to 530 1 to 458       458/459
(99 %)
1 diff
(99.8 %id)
BE388564 endometrium, adenocarcinoma cell line, uterus .q 74 to 693 1 to 622       622/623
(99 %)
8 diff
(98.8 %id)
BF026130 melanotic melanoma, skin .q 74 to 655 1 to 581       581/581
(100 %)
5 diff
(99.2 %id)
AI206270 pooled germ cell tumors .q 75 to 277 203 to 1       203/203
(100 %)
0 diff
(100 %id)
AI700009 pooled germ cell tumors .q 75 to 275 201 to 1       201/201
(100 %)
0 diff
(100 %id)
AI739169 colon, colon tumor, RER+ .q 75 to 275 201 to 1       201/201
(100 %)
0 diff
(100 %id)
AI936399 Kidney .q 75 to 266 192 to 1       192/192
(100 %)
5 diff
(97.4 %id)
BF055985 pooled germ cell tumors .q 75 to 292 225 to 8       218/225
(96 %)
0 diff
(100 %id)
BQ277976 ovary, teratocarcinoma, cell line .q 76 to 737 1 to 668       668/1136
(58 %)
11 diff
(99.1 %id)
BE279422 choriocarcinoma, placenta .q 77 to 735 1 to 663       663/710
(93 %)
14 diff
(98.1 %id)
AA398373   .q 78 to 292 221 to 8       214/221
(96 %)
2 diff
(99.1 %id)
AI245711 Kidney .q 78 to 275 198 to 1       198/198
(100 %)
0 diff
(100 %id)
AI434599 Kidney .q 78 to 275 198 to 1       198/198
(100 %)
0 diff
(100 %id)
BE019565 choriocarcinoma, placenta .q 78 to 330 1 to 253       253/253
(100 %)
0 diff
(100 %id)
BE407549 choriocarcinoma, placenta .q 78 to 742 1 to 682       682/726
(93 %)
37 diff
(95.0 %id)
AA888132 colon, colon tumor RER+ .q 83 to 275 192 to 1       192/195
(98 %)
6 diff
(97.0 %id)
AA582927 colon, colon tumor RER+ .q 84 to 292 214 to 8       207/214
(96 %)
1 diff
(99.6 %id)
AI860164 Kidney .q 84 to 275 192 to 1       192/192
(100 %)
0 diff
(100 %id)
AI392819 B-cell, chronic lymphotic leukemia .q 86 to 292 214 to 8       207/214
(96 %)
0 diff
(100 %id)
AI738729 colon, colon tumor, RER+ .q 86 to 263 178 to 1       178/178
(100 %)
3 diff
(98.4 %id)
AW302243 Kidney .q 86 to 275 190 to 1       190/190
(100 %)
0 diff
(100 %id)
BE385808 melanotic melanoma, skin .q 86 to 659 1 to 575       575/579
(99 %)
3 diff
(99.5 %id)
BF223129 pooled germ cell tumors .q 86 to 281 196 to 1       196/196
(100 %)
0 diff
(100 %id)
BF001402 colon, colon tumor, RER+ .q 87 to 292 213 to 8       206/213
(96 %)
0 diff
(100 %id)
BF001432 colon, colon tumor, RER+ .q 87 to 292 213 to 8       206/213
(96 %)
0 diff
(100 %id)
AI738427 colon, colon tumor, RER+ .q 98 to 292 202 to 8       195/202
(96 %)
0 diff
(100 %id)
BM692408 eye, human retina .q 98 to 289 1 to 192       192/192
(100 %)
0 diff
(100 %id)
AI474889 Kidney .q 102 to 275 174 to 1       174/174
(100 %)
1 diff
(99.5 %id)
AW197199 pooled germ cell tumors .q 104 to 275 172 to 1       172/172
(100 %)
0 diff
(100 %id)
AW197323 pooled germ cell tumors .q 104 to 275 172 to 1       172/172
(100 %)
0 diff
(100 %id)
BE466902 pooled germ cell tumors .q 104 to 292 196 to 8       189/196
(96 %)
0 diff
(100 %id)
BF001738 colon, colon tumor, RER+ .q 113 to 292 187 to 8       180/187
(96 %)
0 diff
(100 %id)
AI568827 Prostate .q 123 to 292 177 to 8       170/177
(96 %)
0 diff
(100 %id)
AA126260 uterus .q 175 to 292 124 to 8   fully sequenced,   117/124
(94 %)
0 diff
(100 %id)
BM052764 Islets of Langerhans, Pancreas .q 175 to 285 111 to 1   fully sequenced,   111/111
(100 %)
1 diff
(99.1 %id)
TI_149289488   .q 189 to 905 798 to 83 L3X L11V A13T S26X A49P ... tiling clone, AAA   716/716
(100 %)
9 diff
(98.8 %id)
BF690236 melanotic melanoma, high MDR (cell line), skin .q 235 to 869 667 to 33 G198S fully sequenced,   635/667
(95 %)
0 diff
(100 %id)
BM042559 melanotic melanoma, cell line, skin .q 261 to 831 569 to 1   fully sequenced,   569/569
(100 %)
2 diff
(99.7 %id)
BM042510 melanotic melanoma, cell line, skin .q 500 to 857 357 to 1   fully sequenced,   357/357
(100 %)
4 diff
(98.9 %id)
BF664406 B-cells, primary B-cells from tonsils (cell line) .r 1 to 721 1 to 712   tiling clone,   712/716
(99 %)
11 diff
(98.5 %id)
AI393970 B-cell, chronic lymphotic leukemia .r 14 to 315 302 to 1   tiling clone,   302/302
(100 %)
1 diff
(99.7 %id)
NM_017900.2   .r 58 to 1047 1 to 990 exact RefSeq, AAA   990/990
(100 %)
0 diff
(100 %id)
BM724902 eye, fetal eye .r 85 to 459 1 to 376   fully sequenced,   376/376
(100 %)
1 diff
(99.8 %id)
BG540232 lung .r 106 to 784 1 to 691   tiling clone,   691/752
(91 %)
17 diff
(97.8 %id)
BG764236 melanotic melanoma, high MDR (cell line), skin .r 185 to 1040 1 to 846 D116M E117K G118A V119S A120R ...     846/846
(100 %)
12 diff
(98.6 %id)
BG830049 epithelioid carcinoma cell line, Pancreas .r 237 to 1042 1 to 807 N129K V130R L131A K132E I133D ...     807/824
(97 %)
14 diff
(98.4 %id)
AI878821 brain, frontal lobe .r 242 to 678 1 to 437   fully sequenced,   437/437
(100 %)
0 diff
(100 %id)
BQ961977 epithelioid carcinoma cell line, Pancreas .r 243 to 1047 1 to 807 K199Q     807/906
(89 %)
6 diff
(99.4 %id)
CB998156 placenta, pre-eclamptic placenta .r 289 to 1016 28 to 757 G188S K199Q     730/757
(96 %)
10 diff
(98.7 %id)
BC062333 Prostate, carcinoma .r 293 to 1040 1 to 748 exact available from MGC, AAA   748/748
(100 %)
0 diff
(100 %id)
BF683373 leiomyosarcoma cell line, uterus .r 293 to 1043 1 to 746 W189L Q190A T191D K193Q I194D ...     746/780
(95 %)
10 diff
(98.8 %id)
BQ670578 epidermoid carcinoma, cell line, salivary gland .r 294 to 1037 6 to 757 Q124X L182A E184G A185S E187R ...     752/962
(78 %)
29 diff
(97.0 %id)
BQ276253 carcinoma, cell line, Prostate .r 295 to 1040 1 to 746 G188S     746/1074
(69 %)
5 diff
(99.6 %id)
BU602936 mixed (pool of 40 RNAs) .r 295 to 1040 1 to 746 G181X G188S R197P K199Q     746/833
(89 %)
10 diff
(98.8 %id)
DA620632   .r 295 to 851 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
BM711264 eye, fetal eyes .r 295 to 627 1 to 333   fully sequenced,   333/333
(100 %)
0 diff
(100 %id)
AK000615   .r 296 to 1047 1 to 752 exact tiling clone, available from FLJ, AAA   752/752
(100 %)
0 diff
(100 %id)
BP231388 muscle .r 296 to 875 1 to 580       580/582
(99 %)
1 diff
(99.9 %id)
BU163828 epidermoid carcinoma, cell line, salivary gland .r 296 to 1042 1 to 747 G181X G188S     747/757
(98 %)
5 diff
(99.4 %id)
BQ879604 epidermoid carcinoma, cell line, salivary gland .r 296 to 1040 1 to 746 A185P E187X G188A W189G Q190R ...     746/920
(81 %)
9 diff
(99.1 %id)
BM836275 stomach .r 297 to 813 1 to 517       517/517
(100 %)
0 diff
(100 %id)
BM698748 eye, fetal eyes .r 301 to 688 1 to 388   fully sequenced,   388/388
(100 %)
0 diff
(100 %id)
BI193842 epithelioid carcinoma cell line, Pancreas .r 302 to 1026 1 to 725 T191N     725/725
(100 %)
3 diff
(99.6 %id)
BM794340 Ascites, stomach .r 302 to 818 1 to 517       517/517
(100 %)
2 diff
(99.7 %id)
BM824236 Ascites, stomach .r 302 to 911 1 to 610       610/610
(100 %)
0 diff
(100 %id)
BG479890 choriocarcinoma, placenta .r 305 to 964 1 to 659       659/659
(100 %)
2 diff
(99.7 %id)
TI_149293956   .r 307 to 1040 820 to 88 exact AAA   733/970
(75 %)
2 diff
(99.8 %id)
BU528036 epidermoid carcinoma, cell line, lung .r 310 to 1026 34 to 752 exact     719/970
(74 %)
14 diff
(98.6 %id)
BE729453 melanotic melanoma, skin .r 312 to 1037 1 to 722 A56P Q57S L58W E59S L60W ...     722/1035
(69 %)
11 diff
(99.0 %id)
BF205930 brain, neuroblastoma .r 313 to 1040 1 to 719 L182* AAA   719/719
(100 %)
16 diff
(97.8 %id)
CB992193 placenta, pre-eclamptic placenta .r 314 to 1040 28 to 754 K193Q AAA   727/754
(96 %)
16 diff
(97.9 %id)
CB997956 placenta, pre-eclamptic placenta .r 314 to 969 28 to 689       662/700
(94 %)
15 diff
(97.9 %id)
BQ672062 epidermoid carcinoma, cell line, salivary gland .r 317 to 1047 1 to 731 G181X AAA   731/731
(100 %)
2 diff
(99.8 %id)
BQ673366 epidermoid carcinoma, cell line, salivary gland .r 317 to 1047 1 to 733 L178A K179E A180G G181R L182G ... AAA   733/733
(100 %)
11 diff
(98.5 %id)
BP245165 Kidney .r 318 to 845 1 to 528       528/534
(98 %)
4 diff
(99.3 %id)
BE263617 lung, small cell carcinoma .r 319 to 908 1 to 589       589/589
(100 %)
1 diff
(99.9 %id)
BG478204 melanotic melanoma, skin .r 320 to 1039 1 to 728 exact     728/950
(76 %)
14 diff
(98.6 %id)
DB449152 testis .r 321 to 738 1 to 418       418/418
(100 %)
0 diff
(100 %id)
CN484942 eye .r 322 to 881 1 to 560       560/560
(100 %)
0 diff
(100 %id)
BM791839 Ascites, stomach .r 322 to 818 1 to 497       497/497
(100 %)
0 diff
(100 %id)
CB151875 cervix, Uterine .r 324 to 885 1 to 562       562/562
(100 %)
1 diff
(99.9 %id)
BF972756 leiomyosarcoma cell line, uterus .r 325 to 1041 1 to 718 exact     718/740
(97 %)
4 diff
(99.5 %id)
CA307137 Alveolar Macrophage, lung .r 331 to 1040 727 to 19 exact AAA   709/709
(100 %)
1 diff
(99.9 %id)
BF684613 leiomyosarcoma cell line, uterus .r 332 to 1049 1 to 723 R20A P21R P22L W23G V25S ...     723/886
(81 %)
14 diff
(98.5 %id)
BG768952 melanotic melanoma, high MDR (cell line), skin .r 332 to 1042 2 to 721 G27V V28S L29A S31A R32A ...     720/748
(96 %)
13 diff
(98.3 %id)
BM796959 Ascites, stomach .r 332 to 648 1 to 317       317/317
(100 %)
0 diff
(100 %id)
BE312488 brain, neuroblastoma .r 333 to 877 1 to 545       545/545
(100 %)
0 diff
(100 %id)
BQ888816 ductal carcinoma, cell line, Pancreas .r 333 to 1047 1 to 715 G181X AAA   715/715
(100 %)
2 diff
(99.8 %id)
BM792623 Ascites, stomach .r 334 to 910 1 to 577       577/577
(100 %)
0 diff
(100 %id)
BU150158 ductal carcinoma, cell line, Pancreas .r 336 to 1040 733 to 27 exact AAA Submitted on the opposite strand 707/853
(82 %)
3 diff
(99.7 %id)
BU167801 melanotic melanoma, cell line, skin .r 338 to 1027 1 to 693 G181R K193Q Y195*     693/942
(73 %)
16 diff
(98.4 %id)
BU857945 adenocarcinoma, cell line, breast .r 338 to 1047 1 to 710 G181X G198X AAA   710/710
(100 %)
0 diff
(100 %id)
TI_159707640   .r 338 to 1040 793 to 92 exact AAA   702/774
(90 %)
2 diff
(99.8 %id)
BE274765 melanotic melanoma, skin .r 341 to 1000 1 to 659 T191N     659/660
(99 %)
4 diff
(99.4 %id)
BE391099 endometrium, adenocarcinoma cell line, uterus .r 341 to 949 1 to 611       611/611
(100 %)
2 diff
(99.7 %id)
BE386268 melanotic melanoma, skin .r 341 to 944 1 to 604       604/604
(100 %)
0 diff
(100 %id)
TI_149293962   .r 342 to 1040 778 to 81 L3X A13P AAA   698/948
(73 %)
2 diff
(99.8 %id)
TI_149297789   .r 342 to 1042 795 to 96 Q9X L10A L11V R12E A13G ... AAA   700/927
(75 %)
3 diff
(99.7 %id)
TI_149309212   .r 346 to 1040 795 to 102 exact AAA   694/936
(74 %)
2 diff
(99.8 %id)
TI_149314770   .r 346 to 1040 774 to 83 L2S L3W R5P L6* AAA   692/962
(71 %)
32 diff
(96.7 %id)
BU197017 ductal carcinoma, cell line, Pancreas .r 351 to 1044 1 to 694 exact     694/886
(78 %)
3 diff
(99.7 %id)
BU629066 cell lines, Chondrosarcoma .r 352 to 1040 707 to 19 G19D AAA   689/689
(100 %)
1 diff
(99.9 %id)
BU682874 lung .r 363 to 1040 696 to 19 exact AAA   678/678
(100 %)
0 diff
(100 %id)
BU682875 lung .r 365 to 1040 694 to 19 L3X A13P AAA   676/676
(100 %)
1 diff
(99.9 %id)
BU687627 lung .r 365 to 1040 694 to 19 exact AAA   676/676
(100 %)
0 diff
(100 %id)
BM982798 lung, Primary Lung Cystic Fibrosis EpithelialCells .r 365 to 1042 695 to 17 Q9X L10A L11V R12E A13G ... AAA   679/679
(100 %)
1 diff
(99.9 %id)
CB851613 lung, Primary Lung Cystic Fibrosis EpithelialCells .r 365 to 1040 694 to 19 exact AAA   676/676
(100 %)
0 diff
(100 %id)
BU628492 Bone, Enchondroma cell line .r 365 to 1040 694 to 19 L3X AAA   676/676
(100 %)
0 diff
(100 %id)
BU628734 Bone, Enchondroma cell line .r 365 to 1040 694 to 19 A13P S26X AAA   676/676
(100 %)
1 diff
(99.9 %id)
BU625803 cell lines, Enchondroma .r 367 to 1046 698 to 19 A13P G19A AAA   680/682
(99 %)
2 diff
(99.8 %id)
EL736156 mixed .r 377 to 832 1 to 456       456/456
(100 %)
4 diff
(99.2 %id)
BM680136 eye, fetal eye .r 399 to 1042 660 to 17   fully sequenced, AAA   644/644
(100 %)
0 diff
(100 %id)
BU628006 Bone, Enchondroma cell line .r 415 to 1042 646 to 19   AAA   628/628
(100 %)
0 diff
(100 %id)
TI_151744609   .r 425 to 1042 44 to 661   AAA Submitted on the opposite strand 620/661
(93 %)
6 diff
(99.1 %id)
BM263342 Pancreas, Purified pancreatic islet .r 428 to 1022 1 to 595     Submitted on the opposite strand 595/595
(100 %)
0 diff
(100 %id)
BM504784 Pancreas, Purified pancreatic islet .r 428 to 1009 1 to 582     Submitted on the opposite strand 582/582
(100 %)
0 diff
(100 %id)
AI073404   .r 429 to 1013 1 to 585     Submitted on the opposite strand 585/585
(100 %)
1 diff
(99.9 %id)
AI144321 B-cell, chronic lymphotic leukemia .r 429 to 905 1 to 477     Submitted on the opposite strand 477/477
(100 %)
0 diff
(100 %id)
AI159931 heart .r 429 to 910 1 to 482     Submitted on the opposite strand 482/482
(100 %)
0 diff
(100 %id)
AI190443 heart .r 429 to 916 1 to 488     Submitted on the opposite strand 488/488
(100 %)
0 diff
(100 %id)
AI183555   .r 429 to 873 1 to 442     Submitted on the opposite strand 442/442
(100 %)
3 diff
(99.4 %id)
AI083893 anaplastic oligodendroglioma, brain .r 429 to 878 1 to 450     Submitted on the opposite strand 450/450
(100 %)
0 diff
(100 %id)
AI201204   .r 429 to 769 1 to 341     Submitted on the opposite strand 341/341
(100 %)
0 diff
(100 %id)
AI199814 placenta .r 429 to 910 1 to 482     Submitted on the opposite strand 482/482
(100 %)
0 diff
(100 %id)
AI357045 pooled germ cell tumors .r 429 to 822 1 to 394     Submitted on the opposite strand 394/394
(100 %)
0 diff
(100 %id)
AI440315 B-cell, chronic lymphotic leukemia .r 429 to 916 1 to 488     Submitted on the opposite strand 488/488
(100 %)
1 diff
(99.8 %id)
AI475812 B-cell, chronic lymphotic leukemia .r 429 to 911 1 to 483     Submitted on the opposite strand 483/483
(100 %)
1 diff
(99.8 %id)
AI475823 B-cell, chronic lymphotic leukemia .r 429 to 917 1 to 489     Submitted on the opposite strand 489/490
(99 %)
2 diff
(99.6 %id)
AI523882 B-cell, chronic lymphotic leukemia .r 429 to 965 1 to 537     Submitted on the opposite strand 537/537
(100 %)
0 diff
(100 %id)
AI590083 anaplastic oligodendroglioma, brain .r 429 to 920 1 to 492     Submitted on the opposite strand 492/492
(100 %)
1 diff
(99.8 %id)
AI582371 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .r 429 to 902 1 to 474     Submitted on the opposite strand 474/474
(100 %)
1 diff
(99.8 %id)
AI568921 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .r 429 to 912 1 to 484     Submitted on the opposite strand 484/484
(100 %)
0 diff
(100 %id)
AI681658 carcinoid, lung .r 429 to 917 1 to 489     Submitted on the opposite strand 489/490
(99 %)
1 diff
(99.8 %id)
AI660849 colon, colonic mucosa from 3 patients with Crohn'sdisease .r 429 to 950 1 to 522     Submitted on the opposite strand 522/522
(100 %)
4 diff
(99.3 %id)
AI860605 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .r 429 to 909 1 to 481     Submitted on the opposite strand 481/481
(100 %)
0 diff
(100 %id)
AI924512 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .r 429 to 916 1 to 488     Submitted on the opposite strand 488/488
(100 %)
0 diff
(100 %id)
AI922946 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .r 429 to 936 1 to 508     Submitted on the opposite strand 508/508
(100 %)
1 diff
(99.9 %id)
AI934661 anaplastic oligodendroglioma, brain .r 429 to 826 1 to 398     Submitted on the opposite strand 398/398
(100 %)
3 diff
(99.3 %id)
AI949773 2 pooled tumors (clear cell type), Kidney .r 429 to 998 1 to 570     Submitted on the opposite strand 570/570
(100 %)
1 diff
(99.9 %id)
AW050805 colon, colonic mucosa from 3 patients with Crohn'sdisease .r 429 to 888 1 to 461     Submitted on the opposite strand 461/461
(100 %)
1 diff
(99.8 %id)
AW166529 cervix .r 429 to 912 1 to 484     Submitted on the opposite strand 484/484
(100 %)
1 diff
(99.8 %id)
BF589305 pooled .r 429 to 935 1 to 507     Submitted on the opposite strand 507/507
(100 %)
1 diff
(99.9 %id)
BE675820 B-cell, chronic lymphotic leukemia .r 429 to 936 1 to 508     Submitted on the opposite strand 508/508
(100 %)
0 diff
(100 %id)
BE676438 B-cell, chronic lymphotic leukemia .r 429 to 916 1 to 488     Submitted on the opposite strand 488/488
(100 %)
0 diff
(100 %id)
BF001218 Prostate .r 429 to 966 1 to 538     Submitted on the opposite strand 538/538
(100 %)
0 diff
(100 %id)
BF061318 fibrotheoma, ovary .r 429 to 902 1 to 474     Submitted on the opposite strand 474/474
(100 %)
0 diff
(100 %id)
BF732724 fibrotheoma, ovary .r 429 to 914 1 to 487     Submitted on the opposite strand 487/487
(100 %)
2 diff
(99.6 %id)
BF057330 fibrotheoma, ovary .r 429 to 921 1 to 493     Submitted on the opposite strand 493/493
(100 %)
1 diff
(99.8 %id)
AI991507 pooled germ cell tumors .r 430 to 886 1 to 457     Submitted on the opposite strand 457/457
(100 %)
3 diff
(99.4 %id)
AW574673 lymph .r 430 to 1005 1 to 576     Submitted on the opposite strand 576/576
(100 %)
3 diff
(99.5 %id)
AW576017 lymph .r 430 to 897 1 to 468     Submitted on the opposite strand 468/468
(100 %)
0 diff
(100 %id)
AW576100 lymph .r 430 to 838 1 to 409     Submitted on the opposite strand 409/409
(100 %)
0 diff
(100 %id)
BF434591 fibrotheoma, ovary .r 430 to 936 1 to 507     Submitted on the opposite strand 507/507
(100 %)
1 diff
(99.9 %id)
BE222601 brain, oligodendroglioma .r 431 to 814 1 to 384     Submitted on the opposite strand 384/384
(100 %)
0 diff
(100 %id)
BU632613 cell lines, Chondrosarcoma .r 434 to 1043 628 to 19   AAA   610/610
(100 %)
0 diff
(100 %id)
BF732557 fibrotheoma, ovary .r 438 to 936 1 to 499     Submitted on the opposite strand 499/499
(100 %)
2 diff
(99.6 %id)
AI031800 parathyroid gland, parathyroid tumor .r 447 to 1044 1 to 598   AAA Submitted on the opposite strand 598/598
(100 %)
2 diff
(99.7 %id)
AI092925 heart .r 447 to 917 1 to 471     Submitted on the opposite strand 471/471
(100 %)
0 diff
(100 %id)
AI148655 placenta .r 447 to 916 1 to 470     Submitted on the opposite strand 470/470
(100 %)
2 diff
(99.6 %id)
AI183424 placenta .r 447 to 886 1 to 440     Submitted on the opposite strand 440/440
(100 %)
0 diff
(100 %id)
AI190226 heart .r 447 to 907 1 to 462     Submitted on the opposite strand 462/462
(100 %)
2 diff
(99.6 %id)
AI335583 uterus .r 447 to 920 1 to 474     Submitted on the opposite strand 474/474
(100 %)
0 diff
(100 %id)
AI356242 anaplastic oligodendroglioma, brain .r 447 to 911 1 to 465     Submitted on the opposite strand 465/465
(100 %)
0 diff
(100 %id)
AI363140 anaplastic oligodendroglioma, brain .r 447 to 911 1 to 465     Submitted on the opposite strand 465/465
(100 %)
0 diff
(100 %id)
AI440468 B-cell, chronic lymphotic leukemia .r 447 to 916 1 to 470     Submitted on the opposite strand 470/470
(100 %)
2 diff
(99.6 %id)
AI818850 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .r 447 to 883 1 to 437     Submitted on the opposite strand 437/437
(100 %)
0 diff
(100 %id)
AI870579 anaplastic oligodendroglioma, brain .r 447 to 935 1 to 489     Submitted on the opposite strand 489/489
(100 %)
0 diff
(100 %id)
AI923210 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .r 447 to 932 1 to 486     Submitted on the opposite strand 486/490
(99 %)
1 diff
(99.8 %id)
AI952988 anaplastic oligodendroglioma, brain .r 447 to 986 1 to 540     Submitted on the opposite strand 540/540
(100 %)
1 diff
(99.9 %id)
AW006792 colon .r 447 to 916 1 to 470     Submitted on the opposite strand 470/470
(100 %)
0 diff
(100 %id)
AW005270 thymus, pooled .r 447 to 895 1 to 449     Submitted on the opposite strand 449/449
(100 %)
0 diff
(100 %id)
BF061160 fibrotheoma, ovary .r 447 to 917 1 to 471     Submitted on the opposite strand 471/471
(100 %)
1 diff
(99.8 %id)
AW027119 thymus, pooled .r 452 to 912 1 to 461     Submitted on the opposite strand 461/462
(99 %)
4 diff
(99.2 %id)
BU681644 lung .r 455 to 1042 603 to 17   AAA   587/587
(100 %)
1 diff
(99.9 %id)
AI609688 ovary, tumor, 5 pooled (see description) .r 458 to 560 1 to 103     Submitted on the opposite strand 103/103
(100 %)
0 diff
(100 %id)
AW150677 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .r 458 to 818 1 to 361     Submitted on the opposite strand 361/361
(100 %)
0 diff
(100 %id)
CK822515 Pancreas, Purified pancreatic islet .r 460 to 1026 1 to 567       567/567
(100 %)
0 diff
(100 %id)
BQ425552 melanotic melanoma, skin .r 462 to 1040 1 to 579   AAA   579/579
(100 %)
0 diff
(100 %id)
BM998732 lung, Metastatic Chondrosarcoma .r 463 to 1043 599 to 19   AAA   581/581
(100 %)
1 diff
(99.9 %id)
BU949807 Pancreas, Purified pancreatic islet .r 463 to 1009 1 to 547     Submitted on the opposite strand 547/547
(100 %)
0 diff
(100 %id)
BU948748 Pancreas, Purified pancreatic islet .r 464 to 914 1 to 451     Submitted on the opposite strand 451/451
(100 %)
0 diff
(100 %id)
AI814303 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .r 465 to 922 1 to 458     Submitted on the opposite strand 458/458
(100 %)
1 diff
(99.8 %id)
CA776376 Pancreas, Purified pancreatic islet .r 467 to 1040 1 to 574     Submitted on the opposite strand 574/574
(100 %)
0 diff
(100 %id)
BU631934 cell lines, Chondrosarcoma .r 469 to 1047 597 to 19   AAA   579/579
(100 %)
1 diff
(99.9 %id)
AI672615 thymus, pooled .r 471 to 925 1 to 455     Submitted on the opposite strand 455/455
(100 %)
2 diff
(99.6 %id)
AW131797 brain, medulloblastoma .r 471 to 925 1 to 455     Submitted on the opposite strand 455/455
(100 %)
0 diff
(100 %id)
W84330 heart .r 472 to 845 1 to 372     Submitted on the opposite strand 372/372
(100 %)
2 diff
(99.5 %id)
AW050629 colon, colonic mucosa from 3 patients with Crohn'sdisease .r 472 to 918 1 to 447     Submitted on the opposite strand 447/447
(100 %)
0 diff
(100 %id)
AA515472 colon .r 473 to 740 1 to 268     Submitted on the opposite strand 268/268
(100 %)
0 diff
(100 %id)
AI092503 heart .r 473 to 948 1 to 476     Submitted on the opposite strand 476/476
(100 %)
0 diff
(100 %id)
AI186815 lung .r 473 to 987 1 to 515     Submitted on the opposite strand 515/515
(100 %)
1 diff
(99.9 %id)
AI338745 lung .r 473 to 916 1 to 444     Submitted on the opposite strand 444/444
(100 %)
0 diff
(100 %id)
AI696150 thymus, pooled .r 473 to 621 1 to 149     Submitted on the opposite strand 149/149
(100 %)
0 diff
(100 %id)
AI673080 thymus, pooled .r 473 to 948 1 to 476     Submitted on the opposite strand 476/476
(100 %)
0 diff
(100 %id)
AI672880 colon, colonic mucosa from 3 patients with Crohn'sdisease .r 473 to 807 1 to 335     Submitted on the opposite strand 335/335
(100 %)
0 diff
(100 %id)
AI660964 colon, colonic mucosa from 5 ulcerative colitispatients .r 473 to 948 1 to 476     Submitted on the opposite strand 476/476
(100 %)
1 diff
(99.8 %id)
AI991885 colon, colonic mucosa from 3 patients with Crohn'sdisease .r 473 to 911 1 to 439     Submitted on the opposite strand 439/439
(100 %)
2 diff
(99.6 %id)
AW050745 colon, colonic mucosa from 3 patients with Crohn'sdisease .r 473 to 718 1 to 246     Submitted on the opposite strand 246/246
(100 %)
0 diff
(100 %id)
AW084573 colon, colonic mucosa from 3 patients with Crohn'sdisease .r 473 to 911 1 to 439     Submitted on the opposite strand 439/439
(100 %)
1 diff
(99.8 %id)
BM670974 eye, lens .r 473 to 1040 586 to 19   AAA   568/568
(100 %)
0 diff
(100 %id)
AI816757 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .r 474 to 936 1 to 463     Submitted on the opposite strand 463/463
(100 %)
1 diff
(99.8 %id)
BE550820 carcinoid, lung .r 475 to 982 1 to 508     Submitted on the opposite strand 508/508
(100 %)
1 diff
(99.9 %id)
AI935233 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .r 476 to 921 1 to 446     Submitted on the opposite strand 446/446
(100 %)
0 diff
(100 %id)
BE465158 carcinoid, lung .r 478 to 992 1 to 515     Submitted on the opposite strand 515/515
(100 %)
0 diff
(100 %id)
AW069176 bone marrow stroma .r 480 to 1040 579 to 19   AAA   561/561
(100 %)
1 diff
(99.9 %id)
AI991037 colon, colonic mucosa from 3 patients with Crohn'sdisease .r 481 to 939 1 to 459     Submitted on the opposite strand 459/459
(100 %)
0 diff
(100 %id)
BU628441 cell lines, Chondrosarcoma .r 485 to 1040 575 to 19   AAA   557/557
(100 %)
2 diff
(99.7 %id)
H25375 breast .r 489 to 758 1 to 267   fully sequenced, Submitted on the opposite strand 267/267
(100 %)
4 diff
(98.6 %id)
CN427599 embryonic stem cells, cell lines H1, H7, andH9 .r 515 to 1037 1 to 523       523/523
(100 %)
1 diff
(99.9 %id)
CA748599 Alveolar Macrophage, lung .r 531 to 1040 528 to 19   AAA   510/510
(100 %)
0 diff
(100 %id)
CD674763 eye, lens .r 536 to 1047 581 to 70   AAA Submitted on the opposite strand 512/512
(100 %)
5 diff
(99.1 %id)
BM704115 eye, Retina Foveal and Macular .r 548 to 1040 522 to 30   AAA Submitted on the opposite strand 493/493
(100 %)
0 diff
(100 %id)
BQ030371 lung, Metastatic Chondrosarcoma .r 564 to 1040 495 to 19   AAA   477/477
(100 %)
1 diff
(99.8 %id)
DB572029 hypothalamus .r 567 to 1040 1 to 473     Submitted on the opposite strand 473/473
(100 %)
1 diff
(99.8 %id)
BM909613 lymph, lymphoma, cell line .r 568 to 1040 1 to 473   AAA   473/473
(100 %)
2 diff
(99.6 %id)
BM720044 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .r 574 to 1043 498 to 29   AAA Submitted on the opposite strand 470/470
(100 %)
1 diff
(99.8 %id)
BM691621 eye, RPE and Choroid .r 592 to 1044 491 to 39   AAA Submitted on the opposite strand 453/453
(100 %)
0 diff
(100 %id)
BM666247 eye, fetal eyes .r 597 to 1040 462 to 19   fully sequenced, AAA   444/444
(100 %)
0 diff
(100 %id)
DB519326 testis .r 612 to 1042 1 to 431     Submitted on the opposite strand 431/431
(100 %)
0 diff
(100 %id)
DB514176 testis .r 613 to 1040 1 to 429     Submitted on the opposite strand 429/429
(100 %)
3 diff
(99.4 %id)
BU950122 Pancreas, Purified pancreatic islet .r 613 to 1039 427 to 1     Submitted on the opposite strand 427/427
(100 %)
1 diff
(99.8 %id)
BQ029134 lung, Metastatic Chondrosarcoma .r 617 to 1040 441 to 19   AAA   423/423
(100 %)
2 diff
(99.6 %id)
BM700411 eye, lens .r 618 to 1040 1 to 423   fully sequenced, AAA   423/423
(100 %)
0 diff
(100 %id)
CB306279 lung, Primary Lung Cystic Fibrosis EpithelialCells .r 639 to 1040 419 to 19   AAA   401/401
(100 %)
1 diff
(99.8 %id)
BM793891 Ascites, stomach .r 643 to 1040 1 to 398   AAA   398/398
(100 %)
0 diff
(100 %id)
AW063880 thymus .r 648 to 915 1 to 268       268/268
(100 %)
0 diff
(100 %id)
AW063916 thymus .r 648 to 929 1 to 282       282/282
(100 %)
0 diff
(100 %id)
AI879382 brain, frontal lobe .r 648 to 1046 407 to 9   fully sequenced,   399/407
(98 %)
4 diff
(99.1 %id)
BU737201 eye, fetal eyes .r 658 to 1040 399 to 19   fully sequenced, AAA   381/381
(100 %)
1 diff
(99.8 %id)
N36528 melanocyte .r 672 to 1040 367 to 1     Submitted on the opposite strand 367/368
(99 %)
2 diff
(99.5 %id)
BM692378 eye, human retina .r 685 to 1040 1 to 356   fully sequenced, AAA   356/356
(100 %)
0 diff
(100 %id)
AI391702 anaplastic oligodendroglioma, brain .r 692 to 1040 349 to 1       349/349
(100 %)
0 diff
(100 %id)
H25374 breast .r 728 to 1043 355 to 41   fully sequenced, AAA Submitted on the opposite strand 315/315
(100 %)
2 diff
(99.4 %id)
BG685651 B-cells, primary B-cells from tonsils (cell line) .r 730 to 1066 1 to 337   tiling clone, AAA   337/337
(100 %)
2 diff
(99.5 %id)
F24203 pectoral muscle (after mastectomy) .r 735 to 1014 1 to 280       280/280
(100 %)
0 diff
(100 %id)
EC455113 Prostate .r 787 to 893 1 to 107       107/107
(100 %)
0 diff
(100 %id)
AW405898 lymph .r 796 to 1047 273 to 22   AAA Submitted on the opposite strand 252/252
(100 %)
0 diff
(100 %id)
BM673624 eye, human retina .r 943 to 1009 67 to 1   fully sequenced,   67/67
(100 %)
0 diff
(100 %id)
BM670528 eye, lens .r 943 to 1040 116 to 19   fully sequenced, AAA   98/98
(100 %)
0 diff
(100 %id)
BY996221   .s 1 to 601 19 to 619 exact tiling clone,   601/619
(97 %)
6 diff
(99.1 %id)
DA373462 thalamus .s 2 to 555 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
DB292020 uterus .s 463 to 1054 2 to 594   capped   593/593
(100 %)
1 diff
(99.9 %id)
DA990389 synovial membrane tissue from rheumatioidarthritis .s 499 to 1033 2 to 536   capped   535/535
(100 %)
0 diff
(100 %id)
BI063254 uterus_tumor .s 503 to 1059 1 to 557       557/557
(100 %)
2 diff
(99.7 %id)
BI063348 uterus_tumor .s 503 to 1059 1 to 557   tiling clone,   557/557
(100 %)
1 diff
(99.9 %id)
CA442612 lung, Lung Focal Fibrosis .t 1 to 454 12 to 463   tiling clone, Submitted on the opposite strand 459/467
(98 %)
6 diff
(98.8 %id)
W18192 whole brain .t 206 to 2145 1 to 1943 R89P S90Q A91R P92S Y93L ... tiling clone, AAA   1943/1943
(100 %)
16 diff
(99.2 %id)
CD519464 White Matter .t 282 to 966 28 to 712       685/942
(72 %)
9 diff
(99.1 %id)
DA252547 caudate nucleus .t 329 to 907 2 to 580   tiling clone, capped   579/579
(100 %)
0 diff
(100 %id)
AA321030 bone marrow .t 503 to 845 1 to 344       344/344
(100 %)
2 diff
(99.5 %id)
AW964584   .t 504 to 1059 1 to 557       557/595
(93 %)
11 diff
(98.2 %id)
BG142177 Islets of Langerhans, Pancreas .t 560 to 1223 1 to 665       665/667
(99 %)
16 diff
(97.7 %id)
AV723014 hypothalamus .t 577 to 1220 52 to 687       640/707
(90 %)
26 diff
(96.4 %id)
AV722448 hypothalamus .t 577 to 959 52 to 429       378/429
(88 %)
6 diff
(98.7 %id)
AV723037 hypothalamus .t 577 to 1222 52 to 690       642/696
(92 %)
15 diff
(97.9 %id)
BP375802 uterus .t 603 to 1169 1 to 566   tiling clone,   566/566
(100 %)
1 diff
(99.9 %id)
AW868801 stomach_normal .t 698 to 1342 639 to 1       639/687
(93 %)
20 diff
(97.1 %id)
BG983858 colon_normal .t 803 to 1119 317 to 1       317/334
(94 %)
0 diff
(100 %id)
BM836635 Ascites, stomach .u 1 to 614 35 to 648 G144X tiling clone,   614/648
(94 %)
6 diff
(99.1 %id)
BG324849 Kidney, renal cell adenocarcinoma .va 1 to 556 8 to 563 exact tiling clone,   563/563
(100 %)
2 diff
(99.7 %id)
AI797782 B-cell, chronic lymphotic leukemia .va 58 to 570 513 to 1       513/513
(100 %)
0 diff
(100 %id)
AI082366 B-cell, chronic lymphotic leukemia .va 151 to 602 452 to 1   tiling clone,   452/452
(100 %)
0 diff
(100 %id)
AI382249 B-cell, chronic lymphotic leukemia .va 300 to 584 285 to 1       285/285
(100 %)
2 diff
(99.3 %id)
TI_157611449   .va 591 to 1227 52 to 688   tiling clone, Submitted on the opposite strand 637/689
(92 %)
20 diff
(97.1 %id)
AW005141 thymus, pooled .va 595 to 1079 1 to 485   tiling clone, Submitted on the opposite strand 485/485
(100 %)
1 diff
(99.8 %id)
DA381452 thalamus .vb 1 to 619 2 to 620 exact tiling clone, capped   619/619
(100 %)
1 diff
(99.9 %id)
BX644818   .vb 111 to 860 1 to 750 exact     750/750
(100 %)
4 diff
(99.5 %id)
BX502689 Liver .vb 136 to 741 1 to 606 exact     606/606
(100 %)
1 diff
(99.9 %id)
DA954161 Spleen .vb 341 to 915 2 to 576   tiling clone, capped   575/575
(100 %)
0 diff
(100 %id)
BE795552 lung, small cell carcinoma .vc 1 to 765 3 to 770 A50G E51R Q52A D54G E55* tiling clone,   770/776
(99 %)
8 diff
(99.0 %id)
BE793412 lung, small cell carcinoma .vc 1 to 771 1 to 771 exact tiling clone,   771/775
(99 %)
3 diff
(99.7 %id)
DA012630 adrenal gland .vd 1 to 518 2 to 519   tiling clone, capped   518/518
(100 %)
0 diff
(100 %id)
DA483152 brain .vd 153 to 925 2 to 781   capped   780/805
(96 %)
18 diff
(97.8 %id)
DA568254 whole embryo, mainly head .vd 188 to 929 2 to 750   capped   749/749
(100 %)
10 diff
(98.7 %id)
DA735308   .vd 273 to 738 2 to 467   capped   466/466
(100 %)
0 diff
(100 %id)
DA977400 synovial membrane tissue from rheumatioidarthritis .vd 499 to 968 2 to 471   tiling clone, capped   470/470
(100 %)
0 diff
(100 %id)
AI192939 lung .ve 1 to 462 1 to 462     Submitted on the opposite strand 462/462
(100 %)
0 diff
(100 %id)
AW263118 pooled .ve 1 to 393 1 to 393     Submitted on the opposite strand 393/393
(100 %)
1 diff
(99.8 %id)
AW663919 pooled .ve 1 to 548 1 to 548 K75R tiling clone, Submitted on the opposite strand 548/549
(99 %)
8 diff
(98.6 %id)
AV647627 corresponding non cancerous liver tissue .vf 1 to 595 1 to 596   tiling clone, Submitted on the opposite strand 596/611
(97 %)
12 diff
(98.1 %id)
AV647780 corresponding non cancerous liver tissue .vf 1 to 426 1 to 426   tiling clone, Submitted on the opposite strand 426/426
(100 %)
0 diff
(100 %id)
DC308778 cerebellum .vf 695 to 1259 1 to 566 R91P L93P L94V P95A G96W ... tiling clone,   566/566
(100 %)
3 diff
(99.5 %id)
DC306530 cerebellum .vf 720 to 1257 1 to 538   tiling clone,   538/538
(100 %)
0 diff
(100 %id)
324 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va, .vb, .vc, .vd, .ve, .vf Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI